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ABSTRACT 
The bitter threshold concentrations for isoflavones for soy flake extract, soy protein 
isolate extract, and soy germ extract in water were 0.023, 0.023, and 0.039 µmol/ml. The 
saponin concentration of the soy flake extract, soy protein isolate extract, and soy germ 
extract at the threshold for milk were 0.115, 0.561, and 0.225 µmol/ml, respectively. The 
bitterness thresholds for isoflavones in the soy flake extract, soy protein isolate extract, and 
soy germ extract in milk were 0.338, 1.09, and 0.776 µmol/ml respectively, and the saponin 
concentrations at threshold were 0.115, 0.561, and 0.225 µmol/ml. 
Control, high oleic, and high cysteine soy flakes were analyzed for storage protein, 
functionality, isoflavone, and saponin content. The starting materials, when analyzed for 
original concentration of glycinin and f3-conglycinin by urea-SDS-PAGE, showed significant 
differences in storage protein compositions between the high oleic flakes and the other two 
flake varieties. The oleic flakes had 10% more glycinin, and 10% less f3-conglycinin than the 
control and cysteine flakes. The high oleic flakes yielded > 70% more total protein in the 
glycinin fraction than the other two varieties. 
The high cysteine flakes produced significantly higher purities of glycinin in the glycinin-
rich fraction at 91 % compared to the oleic at 78% and control flakes at 87% purity 
The purity of the f3-conglycinin in the f3-conglycinin-rich fraction from the high oleic 
soybeans was 19%, with the major component of this fraction being glycinin. A purity of 
74% for the B-conglycinin-rich fraction from the control flakes, and a purity of 67% for high 
cysteine flakes were observed. The control glycinin, intermediate and f3-conglycinin 
fractions all had higher solubilities than these fractions from the high cysteine and high oleic 
flakes 
The glycinin-rich fraction emulsification capacity for all flake varieties was 
significantly lower than the emulsification capacity of the f3-conglycinin-rich fraction 
The high oleic flake glycinin fraction showed better emulsifying capacity compared to the 
glycinin fractions of the other two varieties. 
In this study, in general, the control flakes contained a significantly higher 
concentration of isoflavones at 6.44 µmol/g than the high cysteine flakes at 5.23 µmol/g and 
v 
the high oleic flakes at 6.0lµmol/g. The mass yield of isoflavones for the control, high oleic, 
and high cysteine beans were 374, 398, and 389 µmoles, respectively. 
In general, the saponin concentration in the control, cysteine, and oleic flakes was 
5.48, 5.46, and 3.74 umol/g, respectively. The mass yield of saponins for the control, high 
oleic, and high cysteine beans were 362, 209, and 319 µmoles, respectively. 
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INTRODUCTION 
Soybeans 
The soybean as a crop was grown in the U.S to only a limited extent prior to 1920. 
Processing of domestic soybeans for oil began in 1915 and this stimulated the production of 
soybeans so that by1920, a three-million-bushel crop was produced. Now, approximately 40 
% of the world's soybean supply is produced in the United States (Liu et al., 1997a). The soy 
used as a food ingredient is typically in the form of flour, protein concentrate, protein isolate, 
or oil. Soy ingredients are highly sought after because of their functionality, nutritional 
properties, low cost, and abundance (Zayas et al., 1997). Further growth in the soy market is 
anticipated because of the 1999 Food and Drug Administration ruling that approved the use 
of the label claim, that soybeans can lower cholesterol. With this ruling FDA allowed food 
manufacturers to place a health claim (healthy heart) on the package labels of food products 
containing more than 6.25 g of soy protein per serving. 
Health Benefits 
There has been much attention given to the health effects of soy consumption. 
Soybean saponins and isoflavones have been considered as major active components 
contributing to the cholesterol-lowering effect of soy products. Soy isoflavones have been 
associated with lowering cancer risk, alleviating menopausal symptoms, and improving post-
menopausal bone health. Soybean saponins were reported to inhibit tumor development, and 
have shown antihepatotoxic activity. 
Importance of Study 
Soybeans constitute an enormous source of proteins for human consumption. 
However, soybean proteins must be presented to the consumer in forms that are attractive 
and possess the flavor, texture, and quality desired by the consumer. Soy proteins ideally 
should display many versatile functional and nutritive properties that are suitable for a wide 
range of applications. 
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In this thesis, I will address the issues of flavor, and some functional qualities desired 
from soy producers and consumers. 
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LITERATURE REVIEW 
The Soybean 
The soybean is one of the oldest crops in the Asian world and has been used in 
various forms as a very important source of dietary protein. The amount of protein produced 
by soybeans per unit area of land is higher than that of any other crop. For this reason, 
soybeans can be expected to be a weapon against world hunger. The soybean as a crop was 
grown in the United States to only a limited extent prior to 1920. Processing of domestic 
soybeans for oil began in 1915 and this stimulated the production of soybeans so that 
by1920, a three-million-bushel crop was produced. Now, approximately 40 % of the world's 
soybean supply is produced in the United States (Liu et al., 1997a). The soy used as a food 
ingredient is typically in the form of defatted flour, soy protein concentrate, soy protein 
isolate, or refined oil. The soy ingredients are highly sought after because of their 
functionality, nutritional properties, low cost, and abundance (Zayas et al., 1997). Further 
growth in the soy market is anticipated because of the 1999 Food and Drug Administration 
ruling that approved the use of the label claim that soybeans can lower cholesterol. 
Soybeans can differ in size, shape, and color depending on the variety. They range 
from small, round beans to large, oblong, flattened seeds with yellow, brown, green, or black 
seed coats. The common varieties grown in the United States are nearly spherical in shape 
and yellow seed coat in color. Soybeans used commercially consist of approximately, 90% 
cotyledon, 8% hull, and 2% hypocotyl and plumule. The hull, the outermost part of the 
soybean, is formed by an outer layer of palisade cells, a layer of hourglass cells, compressed 
parenchyma cells, aleurone cells, and layers of endosperm cells. Inside this layers of the 
soybean is the cotyledon. The surface of the cotyledon is covered with an epidermis, and the 
interior is filed with numerous elongated palisade-like cells filled with protein and oil (Wolf 
and Cowan, 1975). The bulk of the proteins are stored in the protein bodies. Isolated protein 
bodies may contain as high as 98% protein (Tombs et al., 1967). The oil is located in 
structures called spherosomes which are interspersed between the protein bodies. Oil and 
protein make up about 60% of the bean, the protein making up 40 %, and the oil, 20 %. The 
remaining part of the soybean consists of carbohydrates including polysaccharides (15%), 
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stachyose (3.8%), raffinose (1.1%), and sucrose (5.0%) (Kawamura et al., 1967). The 
polysaccharides include cellulose, pectins, and hemicelluloses. Other minor constituents 
such as phosphatides, sterols, and ash are also present in the soybean. Oil and protein 
contents depend on variety, soil fertility, and weather conditions (Smith and Circle, 1972). 
Soy storage proteins are considered to be globulins. Globulins are insoluble in water 
in the region of their isoelectric points but will dissolve in the isoelectric state when salts are 
added. If the pH is above or below the isoelectric point, a globulin will dissolve in aqueous 
solutions in the absence of salts (Wolf and Cowan, 1975). Approximately 90% of the 
proteins in soybeans, mostly globulins, exist as dehydrated storage proteins. The remaining 
proteins are intracellular enzymes (lipoxygenase, urease, amylase), hemagglutinins, protein 
inhibitors and membrane lipoproteins (Kinsella, 1979). 
The predominant storage proteins are the 2 major globulin species, P-conglycinin (7 
S) and glycinin (11 S) (Gaylor and Sykes, 1981). P-Conglycinin is a trimer with a molecular 
weight of about 180,000. P-Conglycinin includes a heterogeneous class of glycoproteins 
composed of varying combinations of three possible subunits termed a', with a molecular 
weight of 57,000-58,000, a, with a molecular weight of 57,000, and p, with a molecular 
weight of 42,000 Dalton (Thanh and Shibasaki, 1976a, 1977). The a and a' subunits are 
composed of extension regions, and core regions. The p subunit consists of only the core 
region. The core regions of three subunits exhibit high absolute homologies with one 
another. The a and a' exhibit a homology of 90.4%. The a and p represent a homology of 
76.2% and the a' and p of 75.5%. The extension regions of the a and a' subunits exhibit 
lower absolute homologies of 57.3%, and are rich in acidic amino acids (Maruyama et al., 
1998). All subunits are N-glycosylated, meaning a carbohydrate is linked to the amide 
nitrogen atom or the side chain of a asparagine residue (Utsumi et al., 1997). Circular 
dicroism (CD) spectrascopy show that the core regions of the a and a' subunits have 
secondary structures similar to that of the p subunit, and the extension regions of the a and 
a' subunits have similar secondary structures to each other (Maruyama et al., 1998). The 
subunits are highly negatively charged, compactly folded glycopeptides with significant 
hydrophobic regions (Thanh and Shibasaki, 1978). 
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Glycinin (11 S) is a large oligomeric protein of approximately 360,000 Daltons. The 
glycinin consists of six nonidentical subunits (Plietz et al., 1984 ). Each subunit is composed 
of an acidic and a basic polypeptide chain (Croy et al., 1980, Turner et al., 1981, Weber et 
al., 1981). The acidic polypeptide component is linked to the basic component by a single 
disulfide bond. Initial translation products of glycinin subunits are single polypeptides of 
about 60,000 Daltons that undergo cotranslational and post-translational modification. The 
precursors have a short signal sequence. This is followed by the acidic component, the basic 
component and a short trailer peptide. Five subunit types have been purified and 
characterized by amino acid sequence analysis. All of the subunits are clearly synthesized by 
a family of homologous genes, but can be separated in two groups based on sequence 
homologies (Nielsen et al., 1985). Group I subunits (A1aB2, A1bB1b, A1B1a) are similar in size 
with molecular weights of 58,000. This group is relatively rich in methionine and has about 
90% sequence homology among members. The group II subunits (A3B4, A5A4B3) exhibit a 
similar level of homology among themselves, although they contain less methionine and their 
molecular weights are around 62,000-69,000. Sequence homology between a member of one 
group and a member of the other is only 60-70% (Nielsen, 1985). Wright et al. (1987, 1988) 
aligned the amino acid sequences to maximize the homology among the glycinin type 
proteins from legume and nonlegume seeds. They suggested five genetically variable 
regions. Variable regions are rich in hydrophilic amino acids, indication that variable regions 
are present on the molecular surface. This was confirmed by X-ray crystallography (Adachi 
et al., 2001). 
Soy Glycinin and /3-Conglycinin Fractionation 
In the last fifty years, several soy protein fractionation processes have been published, 
many with the intention to fractionate a high yield of relatively pure glycinin and ~­
conglycinin. Among the known methods developed for fractionating soy protein, one of the 
first attempts was a method using low temperatures, or cryoprecipitation (Wolf, 1956). Wolf 
reported the recovery of a fairly pure glycinin fraction. For purity, the glycinin fraction was 
evaluated by ultracentrifugal analysis, which does not differentiate among different proteins 
of comparative mass. Koshiyama, (1965) reported a procedure for glycinin and ~-
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conglycinin fractionation using cryoprecipitation, salt precipitation, and isoelectric 
precipitation. In this work, the glycinin fraction was first cryoprecipitated, and then 25 mM 
CaCh was added to remove the residual cold-insoluble proteins, or glycinin. The ~­
conglycinin fraction was precipitated by adjusting the pH of the supernatant to 4.5. The 
purities of the proteins were measured after gel filtration by ultracentrifugal analysis, which 
does not differentiate among different proteins of comparable mass. Later, Thanh et al. 
( 1975,197 6b) developed a straight-forward process for glycinin and ~-conglycinin separation 
based on solubilities of the two proteins at pH 6.1-6.6. Tris (THAM) buffer at pH 8.0 
containing 10 mM 2-mercaptoethanol ( ME) was used to extract soy proteins. Glycinin was 
separated by adjusting the pH to 6.4, and centrifuging at 2-5°C. ~-Conglycinin was 
precipitated at pH 4.8 and purified by redissolving the precipitate in the 30 mM M Tris buffer 
and later adjusting the pH to 6.2. The ~-conglycinin fraction was kept at 3-5 °C overnight. 
This fraction was obtained after centrifuging to remove undissolved polymerized forms. The 
glycinin fraction was 79% glycinin, 6% ~-conglycinin, and 15% other components. The ~­
conglycinin fraction was less pure than the glycinin fraction. It contained 52% ~­
conglycinin, 3% glycinin, and 45% other components. Purity was measured by singly radial 
immunodiffusion (lwabuchi et al., 1987). Thanh and Shibasaki (1976b), further purified the 
glycinin and ~-conglycinin fractions obtained by gel filtration on Sepharose 6B. Both 
O'Keefe et al. (1991) and Nagano et al. (1992b) did studies modifying the Thanh et al. 
(1976b) method. O'Keefe et al. (1991) modified the method of Thanh et al. (1976b) to be 
able to improve the purity of crude ~-conglycinin fraction without the affinity 
chromatography step necessary in the Thanh et al. (1976b) method. O'Keefe et al. (1991) 
used three isoelectric precipitations instead of two at pH 6.4, 5.3, and 4.8. The purity of the 
~-conglycinin fraction did increase, however at the expense of yield. Nagano et al. (1992) 
modified the method of Thanh et al. (1976b). In the Nagano et al method, soy proteins were 
extracted by using water at pH 7.5 instead of Tris buffer. Sodium bisulfite was used as a 
reductant, a substance that chemically reduces other substances by donating an electron or 
electrons. Three protein fractions were precipitated at pH 6.4, 5.0, and 4.8 instead of two at 
pH 6.4 and 4.8. The fraction precipitated at pH 6.4 was considered the 11 S fraction. The 
fraction precipitated at 4.8 was considered the 7S fraction, and the fraction precipitated at 5.0 
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was called the insoluble fraction. The Nagano et al. (1992) fractionation process produced 
purities of crude glycinin > 90 % in the crude glycinin fraction and ~-conglycinin of> 90% 
in the crude ~-conglycinin fraction when measured by densitometer scans of gels from 
sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The Nagano et al. 
(1992) laboratory fractionation process was successfully scaled up to pilot plant scale by Wu 
et al. (1999). Kilogram quantities of the individual soy storage protein fraction were 
produced. Three protein fractions, glycinin, an intermediate protein mixture, and ~­
conglycinin, were produced by using water as an extraction buffer and sodium bisulfite as a 
reducing agent and adjusting the pH to 6.4, 5.0, and 4.8 for precipitating the three protein 
fractions. The protein contents by micro-Kjeldahl of glycinin and ~-conglycinin fractions 
were 93 and 98% , respectively. The glycinin and ~-conglycinin purities were 90 and 73% of 
the protein which were comparable to those of the laboratory-scale process. Purity was done 
with urea-sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and gel 
density image analysis. Wu et al. (2000) did further work on the pilot scale using a 
simplified method that resulted in only two fractions produced, glycinin and ~-conglycinin. 
Glycinin was produced by precipitation at pH 6.0 and ~-conglycinin was produced by 
precipitation at pH 7.0 and by using an ultrafiltration membrane system. The yield of 
glycinin fraction was 9. 7% (db), and it had a protein content and purity similar to those 
obtained with the modified Nagano et al. (1992) method. The yield of the ~-conglycinin 
fraction was 19.6% (db), which was twice that of the modified Nagano, et al. (1992) method. 
The protein content of ~-conglycinin was 91.6% (db), and the purity was 62.6% of the 
protein content, which was 9% lower in purity than the modified Nagano et al. (1992) 
method. Purity was analyzed by urea-SDS-PAGE and gel density image analysis. 
Saito et al. (2001) reported a novel method using phytase for separating glycinin and 
~-conglycinin. The glycinin fraction was obtained by adjusting the pH to 6.0, adding 
phytase, and centrifugation. The supernatant was adjusted to pH 5.0 and centrifuged to give 
the ~-conglycinin fraction. From 100 g of defatted soy flakes, 22 % of total protein was in 
the ~-conglycinin fraction and 36 % of total protein was in the glycinin fraction. The purity 
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of each protein obtained by this method was reported to be more than 80% by the 
densitometric analysis after SDS-PAGE. 
Soy Protein Functionality 
Soybeans constitute an enormous source of proteins for human consumption. 
However, soybean proteins must be presented to the consumer in forms that are attractive 
and possess the flavor, texture, and quality desired by the consumer. Soy proteins ideally 
should display many versatile properties that are suitable for a wide range of applications. 
These properties that determine their uses in foods are called protein functional properties. 
Functional properties are those physicochemical properties of food proteins, such as soy 
protein, that determine their behavior in foods during processing, storage, preparation, and 
consumption. These properties resulting from the manner in which proteins interact with 
other components, affect processing applications, food quality, and ultimately, food 
acceptance. 
The use of soy proteins, because of their unique and expansive functional properties, 
is very extensive in foods. Soy flours are used in a wide range of foods, particularly in 
bakery products and cereals. Defatted soy flours are > 50% protein and are processed by 
dehulling, flaking, solvent extraction of oil, flash desolventizing, and milling of the flakes 
obtained. Enzyme-active soy flour is added to white bread and buns for bleaching functions 
(Rackis et al., 1977). Texturized soy flours are used as extenders in chopped meats. 
Soy protein concentrates are used in food and provide improved flavor, color, and 
higher protein options. Soy protein concentrate is 65-70% protein and is prepared from 
dehulled and defatted soybeans processed like soy flours, but then are denatured by acid 
leaching, extraction with aqueous alcohol, or by moist heat. Soy protein concentrates are 
used in sausage, comminuted products, textured meat products, loaves, and meatballs due to 
their capacity to impart and retain structure and bind moisture. 
Soy protein isolates are used in comminuted meats and dairy foods in which 
emulsifying, thickening, and gelling properties are of prime importance (Kinsella, 1985). 
Soy protein isolates are > 90% protein and are prepared from dehulled and defatted soybeans. 
The protein is extracted by weak alkali (pH7.5-10), followed by centrifugation to removed 
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insoluble fiber residue. The resulting extract is acidified whereas most of the protein 
precipitates as curd, separating curd by centrifugation from the soluble oligosaccharides. 
This is followed by multiple washing of the protein curd and spray-drying. Soy protein 
isolates are added to meatballs, frankfurters, and luncheon meats to improve texture and final 
quality. 
Soy products are increasingly used in meats, meat-based products, and processed 
meats (Waggle et al., 1981, Nowacki et al., 1979). Soluble soy proteins are being used in 
hams, pork, and poultry rolls to reduce cookout and improve juiciness. There is an 
increasing potential for soy proteins in reformed restructured meats due to their binding and 
gelation functions. Thus, soy proteins perform several useful functions in meat products 
including water holding, emulsifying, gelling, structure forming, and adhesion. 
It is important to discuss functional difference in traditional soy protein foods, such as 
tofu. Different ratios of glycinin to ~-conglycinin and their effect on functional properties of 
tofu have been studied. Tofu is a soy protein gel, so the amount and possibly the ratio of soy 
storage proteins is critical for tofu quality (Poysa et al., 2002). Several studies found that 
glycinin and ~-conglycinin content of the starting material had some relationships with tofu 
texture. The glycinin content and the glycinin to ~-conglycinin protein ratio were reported to 
correlate positively with tofu gel hardness (Saio et al., 1969, 1979, Kang et al., 1991). In 
contrast, Utsumi and Kinsella, (1985) reported that the ~-conglycinin protein formed harder 
gels than the glycinin protein. Murphy et al., (1997) reported a negative relationship between 
tofu hardness and the glycinin to ~-conglycinin protein ratio of soybeans. Skurray et al., 
(1980) and Taira et al., (1990) found little correlation between the glycinin to ~-conglycinin 
protein ratio and tofu quality. The ambiguity of the studies may show that processing 
differences may have a larger impact on tofu hardness than the glycinin to ~-conglycinin 
ratio. More functionality studies on tofu and other soy products are necessary to enhance 
future applications of soy products. 
Modified Soybeans 
There are key constraints that are associated with soybean end utilization as food, 
including beany flavor of soyfood products, oxidative instability of soy oil, nutrition-related 
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constraints, lack of certain functional properties, flatus, and low consumer acceptance as 
food. For years, a major approach that has been used to address these problems is through 
plant breeding that has been coupled with new techniques like mutagenesis and genetic 
engineering (Liu et al., 1997). This review will discuss the plant breeding techniques. 
A most important factor limiting the use of soybeans as food is the characteristic off-
flavor associated with soybean products, known as beany. There are two major interrelated 
causes for development of such flavors. One is the high proportion of unsaturated fatty 
acids, in the soybean oil fraction, and the other is the abundant presence of lipoxygenases in 
soybeans. Lipoxygenase catalyzes the oxidation of polyunsaturated fatty acids of soy lipids. 
This oxidation process leads to formation of various types of volatile carbonyl compounds, 
including aldehydes, ketones, and alcohols. Many of these compounds have an objectionable 
odor or undesirable flavor, which is responsible for the beany flavor associated with various 
soy products (Robinson et al., 1995). Genetic elimination of the lipoxygenases from the 
soybean seeds has been sought to combat this problem. In general, soybeans contain three 
lipoxygenase isozymes, designated L-1, L-2, and L-3. Through different breeding 
techniques, soybean mutants lacking L-1 or L-2 of the individual lipoxygenase isozymes 
(Kitamura et al., 1984) and even soybeans lacking all the three isozymes (Hajika et al., 1991) 
have been developed. Breeding soybeans lacking lipoxigenase has been shown effective in 
reducing this enzyme's activities in soybean seeds and in controlling off-flavor development 
in the finished products. Kobayashi et al., (1995) reported that almost all the mass-spec 
peaks corresponding to the volatile compounds obtained from soymilk of mutants lacking L-
2 and L-3 or lacking all three were markedly lower than those of a normal variety. Torres 
and Reitmeier, (2001) reported that soymilks made from lipoxygenase-free soybeans had a 
lower intensity in the attributes "raw as hexanal" aroma and "raw as hexanal" flavor than 
soymilks made from normal soybean lines. 
Oxidative stability refers to resistance of an oil to oxidative reaction during storage 
and processing. The outcome of oxidation leads to off-flavor development. Therefore, an oil 
with high stability is desirable. The degree of unsaturation has a great impact on oil stability. 
The more double bonds in the fatty acid chains, the less stable the oil. Regular soy oil 
contains about 11 % palmitic acid, 4% stearic, 23% oleic, 54% linoleic, and 8% linolenic 
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(Smith & Circle, 1972). Because of a large proportion of polyunsaturated fatty acids, 
particularly linolenic acid, soy oil often has a problem oflacking flavor stability during 
processing, storage, and application. Plant breeding has become an alternative approach to 
increase stability of soy oil. One of the initial strategies of genetic modification was to 
reduce the level of linolenic acid (Howell et al., 1972). A level as low as 2.2% and 2.4% of 
linolenic acid has been reached through conventional breeding (Fehr et al., 1992). Soybean 
with reduced linolenic acid was found to result in significant improvement in oxidative 
stability of its oil (Mounts et al., 1994). 
A second strategy to improve oil stability through genetic modification is to breed 
soybeans with high oleic acid levels. Using genetic engineering tools, scientists at DuPont 
have developed high oleic soybean lines that have oleic acid of 80% or higher, with good 
environmental stability (Fader et al., 1995). The high oleic soy oil was reported to have 
greatly improved oxidative and heat stability (Knowlton et al., 1996). A third genetic 
strategy is to breed soybeans higher in saturated fatty acids. This includes soybeans with 
elevated palmitic levels and soybeans with high stearate level. Initial work at Iowa State 
University through chemical mutagenesis led to registration of several soybean mutants with 
high stearate levels (Hammond & Fehr 1989, Bubeck et al., 1989). From these germplasm, 
researchers at private seed companies developed their own lines with high stearate levels. 
Most of these high stearate lines have a stearate level of 20%, or higher, with palmitic acid 
level remaining unchanged or lightly decreased. At refrigerated temperatures, a typical soy 
oil remains liquid whereas the high stearate soy oil becomes solid. Therefore, the modified 
soy oils would be suitable not only for certain frying applications but also for making low to 
zero trans fatty acid shortening and tub margarine (List et al., 1996, Liu et al., 1997b). The 
palmitic acid content in normal soybean cultivars is about 11 %. Several new lines were 
developed, with palmitic levels increased to near 20% or higher (Fehr et al., 1991). A 
performance study showed that high palmitic soybean oils have increased oxidative stability 
and higher solidification temperature compared with normal soybean oil (Shen et al., 1997), 
indicating that such oils, just like high stearate soy oils, would be useful for direct 
applications for frying as well as margarine and shortening. 
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The soybean is a major source of vegetable protein for human and animal nutrition in 
many countries today. Like proteins of other sources, the nutritional quality of soy proteins 
is a function of many factors, including amino acid composition, digestibility, the presence of 
anti-nutritional factors, and amino acid requirements of the organism fed the protein. 
Proteins of high quality are those fully digested, with an amino acid composition closely 
matching the amino acid pattern required for the animal or humans consuming the protein. 
Like most other leguminous proteins, soy protein is low in sulfur-containing amino acids, 
with methionine being considered as the most significant limiting amino acid, followed by 
cysteine, and threonine. The amino acid profile is adequate for humans, but not livestock. In 
feed for animals where soybean is the main protein source, methionine is commonly added as 
a supplement. Therefore, genetic modification to increase methionine content in soybean 
protein would improve its nutritional value for animals. Other amino acids targeted for 
improvement are lysine and cysteine. Progress has been made in breeding new soybean 
varieties with improved amino acid profile through conventional approaches. The B-
conglycinin and glycinin proteins are the major storage proteins in soybeans, accounting to 
about 70% of total seed proteins. Since the glycinin contains significantly more methionine 
and cysteine per unit protein than B-conglycinin protein, any effort in increasing glycinin to 
B-conglycinin ratio would lead to improvements in amino acid profile of soy proteins. 
Therefore, mutants lacking one or two subunits of B-conglycinin protein would have higher 
contents of methionine and cysteine (Kitamura et al., 1995). 
Molecular strategies have been seriously pursued. One example is the successful 
transformation of Brazil nut methionine rich protein cDNA into soybeans by Pioneer Hi-Bred 
International. Transgenic soybean lines showed accumulation of Brazil nut methionine rich 
protein of up to 8% of the total protein, equivalent to a 26% gain in methionine. 
Unfortunately, the transgenic soybean has been shown to contain a major Brazil-nut allergen, 
the 2S albumin (Nordlee et al., 1996). As a result, the program was terminated. Meanwhile, 
by expressing a methionine rich zein from maize, DuPont obtained soybeans with seed 
methionine contents up to 75% higher than typical soybeans (Kerr et al., 1996). 
Protein digestibility is defined as a percentage of protein absorbed after ingestion of a 
certain amount of protein by humans or animals. It is a major index of protein quality. In 
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food, protein is mixed with other components naturally present in soybeans, such as the 
naturally-occuring biological active trypsin inhibitors and phytate. These two components 
are thought to be the major factors that affect soy protein digestibility. 
The proteinase inhibitors, which have been isolated from soybeans, fall into two 
types: Kunitz trypsin inhibitor and Bowman-Birk inhibitor. The significance of soybean 
trypsin inhibitors lies in their nutritional implications towards both human and animals. Their 
presence reduces digestibility of proteins through decreasing or inhibiting the action of 
pancreatic enzymes and causing hypertrophy of the pancreas shown in some small animals, 
like rats and chicks (Liener et al., 1994). Efforts have been made in lowering trypsin 
inhibitors in soybeans through plant breeding. Mutants lacking Kunitz trypsin inhibitor (Orf 
and Hymowitz 1979) or Bowman-Birk trypsin inhibitor (Stahlhut and Hymowitz 1983) have 
been reported. 
Flatulence, excessive accumulation of gas in the stomach and intestine, is another 
factor limiting consumption of certain types of soy foods, particularly of soy flour and 
cooked or roasted whole soybeans. The problem is widely believed to result from the 
presence of a-linked oligosaccharides, mainly raffinose and stachyose in soybeans. The two 
oligosaccharides are non-reducing, containing fructose, glucose, and galactose as 3 and 4 
units, respectively. Human and monogastric animals lack a-1,6-galactosidase in their 
intestinal mucosa. When ingested, these soluble sugars remain unabsorbed, pass on to the 
lower intestinal tract, where they are metabolized by intestinal microflora which contain the 
enzyme a-1,6-galactosidase and due to the anaerobic environment, fermentation, leading to 
the production of gases (Lien er et al., 1994 ). Because of their indigestibility, their presence 
causes reduced metabolizable energy in feed for pigs and poultry (Coon et al., 1988). An 
ultimate solution to the flatulence problem would be the genetic removal of oligosaccharides 
by plant breeding. It is known that there is a considerable variation in raffinose (0.1-0.9%) 
and stachyose (1.4-4.1 % ) among varieties of soybeans (Hymowitz et al., 1972). So, it is 
possible to breed lines that have low amounts of oligosaccharides through natural selection. 
Indeed, scientists at DuPont have successfully used two separate methods of conventional 
breeding, germplasm screening and chemical mutagenesis, and developed soybean strains 
with low raffinose saccaride contents. Soybean meal prepared from these novel varieties 
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display improved metabolizable energy in poultry and reduced incidence of flatulence in 
human subjects (Kerr et al., 1996). 
Soy Jsojlavones 
Isoflavones are plant compounds, which belong to a class known as phytoestrogens or 
plant estrogens that are particularly present in soy and soy based foods and are present in a 
small number of other plant foods, some including clover, alfalfa, and garbanzo beans. 
(Wang and Murphy, 1994). Isoflavone data from Murphy et al., (1999) reports tofu, miso 
and tempeh to have total isoflavone contents of 1727, 228, and 538 µg isoflavones/g product, 
respectively. Murphy et al., (1999) reported on isoflavone content of soy/meat analogues, 
including soy chicken, meatless franks, soy burgers, and soy links to be 147, 38, 82, and 38 
µg total isoflavone I g product. 
Genistein, daidzein, and glycitein are the aglucons of soy isoflaovones. For each of 
these aglucons, there are three additional major isomer forms called the ~-glucosides, 
including genistin, daidzin, and glycitin, the 6"-0.malonyl-P-glucosides, and the 6"-0. 
acetyl-P-glucosides (Figure 1 ). Heat, moisture, and P-glucosidases are the most important 
factors in changing isoflavone distribution. Soybeans and soy flour are high in 
malonylglucosides, but heat processed soy products, such as roasted soybeans and texturized 
vegetable protein, have distributions shifted substantially from malonylglucosides toward 
acetylglucosides. Fermented foods, such as tempeh and miso, have their isoflavone 
distributions shifted toward the aglucons due to the action of fungal P-glucosidases Wang 
and Murphy (1994). Coward et al., (1998), evaluated effects of cooking on isoflavones in 
soyfoods. These authors found that baking processed soy products led to conversion of 
malonyglucosides to ~-glucosides, but frying tended to promote the conversion of 
malonylglucosdes to acetlyglucosides, due to decarboxylation of the malonylglucosides. 
They indicated that as food received excessive heat treatment, aglucon concentration 
increased and total isoflavone extractable content decreased. They suggested that dry heat 
has a tendency to transform malonylglucosides to acetylglucosides, while moist heat has a 
tendency to transform malonylglucosides to ~-glucosides, but showed no experimental data 
to support this hypothesis. 
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Figure 1. Isotlavone structures 
Plant estrogens have a structural and a functional similarity to the human hormone 
estrogen. Isoflavones, similar to the female hormone, estrogen, bind to estrogen receptors on 
cells of different organs in the human body. The binding affinity to the receptors of the plant 
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estrogens is, however, much weaker than that of the human estrogen. The relative binding 
affinity of genistein, an isoflavone, has been shown to be only 0.0125 compared with 1.0 for 
estradiol (Markiewicz et al., 1993), and the relative estrogenic potency has been calculated to 
be 0.0008 versus 1.0 for estradiol (Miksicek et al., 1993). Recent research has shown that 
cells have two types of estrogen receptors, a and ~· Human estrogen has a high binding 
affinity for the a receptor while isoflavones have a high affinity for the ~ receptor (Brouns et 
al., 2002). It has been reported that isoflavones may have an estrogenic as well as an anti-
estrogenic effect in the human body. Most probably the level of endogenous estrogen plays a 
role in this respect. In a situation where the amount of circulating estrogen is low, like in 
post-menopausal women, the binding of natural plant estrogens to cells will increase the 
overall estrogen effect, an agonistic action. This is assumed to have an influence in all 
conditions where low estrogen levels have negative effects on cell metabolism and organ 
function. In the case that normal estrogen levels are present, binding to cell receptors may 
offset the estrogen effect. This will be an anti-estrogenic action (Korach, 1998). 
Isoflavones and Health-Related Issues 
Since several chronic diseases of menopausal women such as breast cancer, colon 
cancer and arteriosclerotic cardiovascular disease in W estem nations are much less 
prominent in Pacific Rim nations where traditional diets include substantial intake of soy 
foods rich in isoflavones, the explanatory hypothesis for these differences is that intake of 
phytochemicals accounts for these differences in disease occurrence (Hughes 1997, 
Adlercreutz et al., 1997, Messina et al., 1994). 
Menopausal symptoms 
Isoflavones do have a much weaker binding affinity than estradiol, but when 
consumed in high concentrations ( 40 mg/day), isoflavones have the potential to mimic the 
effects of exogenous estrogens such as in hormone replacement therapy. Evidence for this 
was found by Cassidy et al., (1994, 1995). Controlled intervention studies in premenopausal 
women provide direct evidence to suggest that diets containing isoflavones can produce 
estrogenic effects in women of reproductive age. A daily intake of textured vegetable protein 
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containing 45 mg isoflavones modified characteristics of the menstrual cycle of healthy 
premenopausal women and suppressed the magnitude of the normal mid-cycle surge of 
follicle-stimulating hormone and lutenizing hormone. This effect was not seen with an 
isoflavone-:free soybean protein, suggesting that the isoflavone fraction exerts this endocrine 
modifying effect, which occurs at the level of the hypothalamic pituitary-gonadal axis. 
These particular studies were done monitoring only one menstral cycle. In studies examining 
more than one menstral cycle, results have been mixed. Nagata et al., (1998) examined three 
menstral cycles for folecular phase blood levels and changes in cycle length upon ingesting 
68 mg/day isoflavones. The study shows a decreased level of estrone and estradiol by 23 and 
27% in the blood and an increase in cycle length of two days. Wu et al., (2000) studied three 
menstrual cycles after feeding 32 mg/day isoflavones. The study showed a statistically 
significant change in reduction in serum luteal estradiol level. This studied showed no 
changes in folicular phase estradiol, progesterol, or menstrual cycle length. Martini et al., 
(1999) claims that 38mg/day of isoflavones had no effect on menstrual cycle length or serum 
sex hormones. 
One of the most disruptive and classic symptoms of menopause is the hot flash. In 
Western societies it is the most prevalent symptoms of menopause, although the prevalence 
is much lower in Japan (Kronenberg et al., 1994 ). The rarity of this problem in soybean-
consuming societies such as Japan, has prompted some investigations to determine whether 
isoflavones may be a factor for the lower prevalence of the hot flash in Western societies. 
Hot flashes are related to the fall in circulating estrogen, rather than absolute levels, and are 
associated with surges of gonadotrophins. Two studies have shown that phyto-oestrogens, 
lower plasma gonadotrophins after the menopause (Wilcox et al., 1990, Cassidy et al., 1997). 
However, two other studies showed no effects (Baird et al., 1995, Murkies et al., 1995). 
Several studies have concluded that hot flashes are reduced in :frequency and intensity and 
that other symptoms such as vaginal cell maturation and dryness were improved, as well as 
the global sense of physical well being with the treatment of isoflavones (Adlercreutz et al., 
1992, Burke et al., 1996, Washburn et al., 1996). Murkies et al., (1995) examined hot 
flashed directly, and reported an improvement with 45 g soybean flour/day, but an 
improvement occurred also with white wheat flour, which contains no phyto-estrogens. 
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Baird et al., (1995) investigated the effects of phytoestrogen supplements on vaginal 
cytology, and found an increase in cell proliferation, which is an indication of estrogenic 
activity with reversal of menopausal atrophy. In that particular study, subjects were given 
165 mg isoflavones per day. A third study (Murkies et al., 1995) asked post-menopausal 
women to add 45 g soybean four daily to their diets, yet no effects were found. Following 
these studies, Scambia et al., (2000) supplied 50 mg isoflavones, for a period of 6 weeks after 
which the isoflavones were combined with conjugated equine estrogens for a period of 4 
weeks. From week 10 to week 12 no isoflavones but only a combined progesteron-estrogen 
supplement was given. It was observed that both the number and the severity of hot flashes 
was significantly reduced as a result of the soy isoflavones. The placebo group experienced a 
decrease of24% hot flashes after 6 weeks compared with 45% decrease in the isoflavone 
group. Interestingly, when continuing in combination with the estrogen supplement, both 
placebo and isoflavone group reduced the frequency number without differences between the 
two groups. Under these study conditions soy isoflavones were as effective as oral estrogens 
in reducing hot flashes. 
Osteoporosis and Jsoflavones 
Osteoporosis is defined as a condition in which the amount of bone per unit volume is 
decreased, but the composition remains unchanged. The bone becomes porous due to an 
imbalance in the forming and resorbing bone cells, causing structural weakness. 
Osteoporosis in women is particularly associated with the menopause, since the loss of 
estrogen accelerates bone loss (Bingham et al., 1998). The hormonal effects of isoflavones, 
coupled with the comparative rarity of the disease in populations consuming soybean, such as 
the Japanese population, has also prompted investigation of isoflavones in the diet and the 
effect on osteoporosis. Post-menopausal women in particular may benefit from dietary 
supplementation with isoflavone-enriched soybean products to maintain bone mass. Potter et 
al., (1998) reported that soybean supplementation of sixty-six postmenopausal women 
compared bone measurements at baseline and 6 months after feeding a soybean-protein 
supplement enriched in genistein and daidzein with doses of approximately 56 or 990 mg of 
isoflavones/d, compared with treatment with a casein/non-fat dry milk supplement without 
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isoflavones. The higher dose resulted in significant improvements (P<0.05) in both bone 
mineral density and content of lumbar vertebrae relative to the control group, with no 
significant benefit in subjects receiving the lower dose. These findings, which illustrate the 
positive responses of vertebral bone mineral density of the postmenopausal women in the 
study, suggest that a threshold dose exists for any benefit of isoflavones on bone mineral 
density. Longer prospective studies examining the effects of isoflavones on bone parameters 
of postmenopausal women are needed to clarify effective doses and whether other skeletal 
sites will also benefit from isoflavones over a longer time frame of treatment. Some 
evidence is also available that consumption of soybean proteins can reduce urinary markers 
of bone resorption. Pansini et al., (1997) reported that non-osteroporotic, post-menopausal 
women who consumed 60 g isolated soybean proteins daily for 3 months had significant 
reductions in excretion of two urinary markers, deoxypyridinoline and N-telpeptide. Alekel 
et al., (2000) examined the effect of soy protein isolate with and without isoflavones on bone 
in peri-menopausal women. The study was done for 24 weeks with consumption of soy 
protein isolate with isoflavones (80 mg/day) and soy protein isolate without isoflavones. 
There was a control group fed whey protein. In this study, the percentage change in lumbar 
spine bone mineral density, and bone mineral content did not differ from zero in the two soy 
protein isolate groups, but loss occurred in the control group. After contrast coding using 
analyses of covariance with bone mineral density and bone mineral content as the outcome, it 
was concluded that soy isoflavones, not soy protein without isoflavones, attenuated bone loss 
from the lumbar spine in peri-menopausal women. There have been a few studies reporting 
the skeletal effects of isoflavones on rats. Arjmandi et al., (1996) reported that feeding an 
isoflavone-containing soybean protein-based diet to rats resulted in retention of significantly 
more bone than feeding a casein-based diet. Purified genistein also promoted a similar 
improvement in femur bone mass (Blair et al., 1996). Relatively few primate studies of the 
effects of isoflavones on bone mass have been published and positive effects of isoflavones 
on retention of bone after ovariectomy in non-human primates have been difficult to 
demonstrate. One study in which primates were treated with a single dose of 28 mg per 
animal of isoflavones for 2 years has been published (Jayo et al., 1996). No positive effects 
of isoflavones on bone were reported. An additional study in monkeys examined the rate of 
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bone formation in cortical bone (Lees and Ginn, 1998). In this study, bone was collected 7 
months after feeding on either casein or soybean-based diets. The soybean-based diet 
consisted of 45 mg of isoflavones per day. The authors concluded that the isoflavones in the 
dietary soybean isolate were not effective in improving bone measurements. These 
published results support the concept that a threshold of isoflavones needs to be consumed 
for a sufficienty long period of time, months or years depending on the species, before any 
measurable effects on bone mass and density can be observed. 
Cardiovascular Protection and Isoflavones 
Evidence for an effect of isoflavones on plasma cholesterol concentrations has been 
demonstrated in rats, hamsters, nonhuman primates, and humans. Balmir et al., (1996), 
reported that rats were fed for 28 d on diets containing soybean protein without isoflavones 
(soy(-)), soybean protein with isoflavones (soy(+)), casein, and casein plus isoflavones 
(casein(+)). The soybean protein with isoflavones contained only the naturally intact 
isoflavone with no additional isoflavones added. For the casein(+) group, 0.36mg of 
isoflavone extract was added per g protein. The groups fed the casein(+), soy(-), and soy(+) 
had significantly lower LDL-cholesterol concentrations than the casein group. The HDL-
cholesterol concentrations tended to be higher in the two groups fed the diets containing 
isoflavones. In a second study, Balmir et al., (1996) fed hamsters diets of either casein, 
casein(+), soy(+), soy plus additional isoflavones (soy(++)), and casein plus extra isoflavones 
(casein++). The casein, casein(+), and soy(+) diets were the same as described earlier. 
Two additional groups were included in this study, a group fed on the unextracted soybean 
protein with 0.36 mg isoflavoness added per g protien (soy++) and a group fed on casein 
with 0.72 mg isoflavones added per g protein (casein++). The hamsters were given the diet 
for 28 days. The soy(+), soy(++), and casein(+) groups had significantly lower LDL, and 
VLDL-cholesterol than for the casein group. While both soybean protein and the isoflavone-
containing extract lowered LDL and VLDL-cholesterol concentrations, no additional benefit 
was seen for the groups receiving the higher doses of isoflavone extract. Kirk et al., ( 1998) 
reported that they fed diets containing soy protein isolate with isoflavones and soy protein 
isolate without isoflavones to wild-type mice and LDL receptor-deficient mice. Among the 
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wild-type mice, the soy with isoflavones fed group had significantly lower total and LDL and 
VLDL cholesterol concentrations than the mice fed the soy without isoflavones diet. Among 
the LDL receptor-deficient mice, no significant difference was observed in total plasma 
cholesterol between diet groups. The authors interpreted this to suggest that soybean 
isoflavones might lower plasma cholesterol concentration by increasing LDL receptor 
activity. In a study done with non-human primates (Anthony et al., 1996), diets containing 
soy protein with and without isoflavones were evaluated. Plasma LDL and VLDL-
cholesterol concentrations were significantly lower with the soy protein plus isoflavone diet 
in both males and females. Additionally, in the females, the soy protein plus isoflavones diet 
consumption resulted in significantly improved GDL-cholesterol concentrations relative to 
when they were fed on the soy protein diet without isoflavones. In two other studies with 
non-human primates (Anthony et al., 1997, 1998), young monkeys were fed diets containing 
either casein and lactalbumin, soy protein isolate with isoflavones, or soy protein isolate 
without isoflavones. The was a large LDL and VLDL-cholesterol-lowering effect and HDL-
cholesterol-raising effect of the isoflavone intact soybean protein relative to the soy protein 
isolate without isoflavones observed in both males and females. Crouse et al., (1998) 
reported that mildly hypercholesterolaemic men and women were treated with protein 
supplements that contained casein, soybean protein isolate containing 3 mg isoflavones, or 
soybean protein isolate containing 27 mg, 37 mg, or 62 mg isoflavones/d. The 62 mg 
isoflavone group had significantly lower LDL-cholesterol concentrations than the casein 
group, while the soy protein isolate without isoflavones group had no effect. The authors 
reported a dose-response relationship with progressively lower total and LDL-cholesterol 
concentrations with increasing isoflavone dose, also. A similar study was done by Baum et 
al., (1998) in postmenopausal women. This study also concluded that soy protein isolate 
with isoflavones intact significantly lowered LDL and VLDL-cholesterol and higher HDL-
cholesterol concentrations relative to the control group. Unlike the previous study, no 
evidence was found of a dose-response effect on these endpoints. Studies have been done 
administering purified isoflavones instead of isoflavones plus soy protein to subjects. In one 
study (Nestel et al., 1997) menopausal and perimenopausal women were treated with either 
purified isoflavone pills containing about 80 mg isoflavones. These investigators found no 
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effect on plasma lipids. In a second study, men and postmenopausal women were treated 
with purified isoflavones pills containing 55 mg isoflavones. No effect was found on plasma 
lipid and lipoprotein concentrations (Hodgson et al., 1998). 
Kirk et al., ( 1998) recently evaluated the effects of diets containing either intact or 
phytochemical extracted soybean on atherosclerosis in mice. In the mice, lesion area was 
significantly smaller in those fed on intact soybean protein compared with phytochemical-
extracted soy protein. 
Cancer and lsojlavones 
Published data suggest that soy isoflavones may reduce the risk of a variety of 
cancers, and in particular, breast and prostate cancer. Recently, a case-control study by Lee 
et al., (1991) in Singapore found that the regular consumption of soybean foods was 
associated with a marked decreased risk of breast cancer in premenopausal women, but not in 
postmenopausal women. Similarly, a Japanese case-control study found that soybean intake 
was associated with a decreased risk of breast cancer in premenopausal women, but not 
postmenopausal women (Hirose et al., 1985). In contrast to those studies, a case-control 
study involving two different locations in China, failed to find an association between 
soybean intake and breast cancer risk in either pre- or postmenopausal women (Yuan et al., 
1995). The only case control study thus far conducted in the USA to examine the 
relationship between soybean intake and breast cancer risk found that tofu consumption was 
protective in both pre- and postmenopausal Asian women (Wu et al., 1996). However, the 
overall intake of tofu among the subjects in this study was relatively low; the highest quartile 
of intake included women who consumed tofu as little as 50 times/year. Also, tofu was 
protective primarily in Asian women born in Asia who migrated to the West and not an 
Asian born in the USA (Wu et al., 1998). Finally, in the prospective Iowa Women's Study 
involving over 34,000 women, after 8 years of follow-up, tofu intake was associated with a 
modest decrease in postmenopausal breast cancer risk. The difference was not significantly 
different (Greenstein et al., 1996). In addition to the limited number of epidemiological 
studies that quantified soybean intake, Ingram et al., (1997), found an inverse relationship 
between the risk of both pre- and postmenopausal breast cancer and the urinary excretion of 
23 
isoflavonoids. Several animal studies have examined the effect of diets containing soybean 
isoflavones on experimental mammary cancer. In one study, Baggott et al., (1990) found that 
the number of dimethylbenz(a)anthracene-induced mammary tumors was decreased by 
approximately 30% in rats fed on a diet containing 200 g miso/kg diet. In the other study, by 
Gotoh et al., (1998a) a diet containing 100 g miso/kg diet reduced N-nitroso-N-methylurea 
(MNU)-induced mammary tumor number by about 50%. This appeared to be a function 
primarily of a delay in tumor appearance. In a follow-up study Gotoh et al., (1998b), a diet 
containing 100 g miso/kg diet was shown to be effective in reducing tumor number by about 
50% in rats. An additional two studies examined the effects of isolated isoflavones on 
chemically-induced mammary cancer in mature animals. Constantinou et al., (1996) found 
that neither isolated genistein nor daidzein affected MNU-induced mammary tumor 
incidence. Although both isoflavones reduced tumor number by approximately 20%, this 
reduction was no statistically significant. Similarly, Murillo et al., (1998) found that 
genistein had no effect on MNU-induced mammary carcinogenesis. Several reports have 
shown that early exposure, during either the neonatal or prepubertal period of life, to 
genistein markedly inhibits the development of dimethyl-benz(a)anthracene-induced 
mammary tumors in rodents and increases the latency period (Brown and Lamartiniere, 
1995; Lamartiniere et al., 1995; Murrill et al., 1996). Genistein appears to reduce 
carcinogenesis by stimulating mammary development and making this tissue less sensitive to 
the carcinogenic effects of dimethybenz(a)anthracene. 
In a Japanese study, no significant association between soybean paste soup and 
prostate cancer risk was noted (Hirayama et al., 1979). There was not a consistent 
relationship for miso soup with prostate cancer evident when comparing cancer patients with 
patients with hyperplastic disease and control (Oishi et al., 1988). In contrast, in animal 
studies, Zhang et al., (1997) found that in rats fed on a diet containing soybean flour and 
implanted with rat prostate adencarcinoma tumors, tumor growth was significantly retarded 
compared with animals fed on the control diet. Schleicher et al., (1998) found that genistein 
given subcutaneously inhibited the development of prostate tumors in rats implanted with 
prostate carcinoma cells. Rats given genistein developed fewer tumors and fewer invasive 
tumors and no genistein-treated animals developed lung metastases. Zhou et al., (1998) 
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found that the addition of an isoflavone rich concentrate significantly reduced tumor volume 
in immunodeficient mice inoculate with human prostate adenocarcinoma cell line cells. 
Wang et al., (1995) found that dietary genistein inhibited the growth of human prostate 
adenocarcinoma cell line cells implanted into mice. 
Soyasaponins 
Soyasaponins are glycosidic compounds that are present in most plants (Figure 2). 
They are composed of a lipid-soluble aglycon (sapogenol) consisting of either a sterol or a 
triterpenoid and water-soluble sugar residues differing in type and amount of sugars. When 
the sugar are added to the sapogenol, the resulting compounds are called glycosides. The 
most common sugars that are added to the sapogenols to form glycosides are glucose, 
arabinose, glucuronic acid, and xylose. The glycosides are highly surface-active due to their 
amphiphilic nature (Rao et al., 1995). More than 20 saponins have been identified from 
soybean extract that vary in the structure of the sapogenin aglycone and their glycosides. 
The soy saponins are divided into three groups based on the structure of the aglycon moiety, 
the A, B, and E saponins (glucosides of the soyasapogenols A, B, and E) (Shiraiwa et al., 
1991 ). The B and E group saponins are present in the soybean as conjugates with the 
unusual sugar 2,3-dihydro-2,5-dihydroxy-6-methyl-4H-pyran-4-one (DDMP) attached by an 
acetyl linkage to the C-22 position of the sapogenol moiety (Berhow et al., 2000). Kudou et 
al., (1992, 1993) investigated the composition and the structures of the native group B 
saponin in soybean seed and isolated five kinds of saponins named soyasaponins ag, ~g, ~a, 
yg, and ya, according to elution order during HPLC. The structures were characterized as 
having a DDMP moiety attached via labile ether linkage to the C-22 hydroxyl of 
soyasaponins I, II, III, IV, and V, with an absorption maximum at 292 nm. Kudou et al., 
(1992) reported the DDMP-conjugated soysaponins ag, ~g, and ~a were the genuine group B 
saponins present in soybeans and that their non-DDMP counterparts, soyasaponins V, I, and 
II, were products formed during heat treatment. The DDMP saponin bond is labile. Loss of 
this moiety from soy saponins ~g, ~a, yg, ya, and ag yields soy saponins I, II, III, IV, and V, 
respectively. The DDMP saponins were detected as major saponin constituents using much 
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milder than normal extraction conditions, while group B and E saponins, the saponins 
normally found when using hot solvent extraction condition, were not detected. 
r~----~·-~~-~-----, . ' 0 I 
OH 
°"o-i C!-1:3 
C!-1:3 : I 
L-------------···-J 
DDMP 
Ri R2 DDMP 
Soy saponin ~g CH20H a-L-Rha y 
Soy saponin I CH20H a-L-Rha N 
Soy saponin ~a H a-L-Rha y 
Soy saponin II H a-L-Rha N 
Soy saponin yg CH20H H y 
Soy saponin III CH20H H N 
Soy saponin ya H H y 
Soy saponin IV H H N 
Soy saponin ag CH20H ~-D-Glc y 
Soy saponin V CH20H ~-D-Glc N 
Figure 2. Structures of group B soybean saponins (Kudou, et al., 1994) 
Rha: rhamnosyl; Glc: glucosyl; DDMP: 2,3,-dihydro-2,5-dihydroxy-6-methyl-4H-
pyran-4-one; Y: yes; N: no. 
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Therefore, it is strongly suggested that these DDMP saponins are genuine saponins in intact 
soybeans. Soybeans contain five kinds of group B saponins, soyasaponin I and II in the 
hypocotyls, and soyasaponin II, II, IV, and V in the cotyledon (Shimoyamada et al., 1990, 
1991). There are few reports regarding group E saponin content. Kitagawa et al., (1988) 
suggested the interconversion of soyasapogenol B into E by photo-oxidation. Hu et al., 
(2002) developed a high-performance liquid chromatographic method for the isolation and 
quantitative determination of the group B soysaponins, including the (DDMP)-conjugated 
soyasaponins ag, ~g, and ~a, and their non-DDMP counterparts, soyasaponins V, I, and II, 
respectively. Hu et al., (2002) published a list of many soy ingredients and soy products 
analyzed for saponin concentration. Some of the soy foods and saponin contents include 
tofu, tempeh, soy milk and soy protein isolate at 0.59, 1.53, 0.47, and 9.51 µmole total 
saponins I g product. 
Saponin Related Health Effects 
Cancer and Saponins 
First, the low incidence of cancer combined with the high intake of soybeans in 
Japanese living in Japan compared with Japanese who immigrated to the West suggests that 
saponins may play an important role in cancer protection (Dunn et al., 1975). The active 
component in several herbal medicines that are used as chemotherapeutic agents in Eastern 
countries were shown to be saponins. Yunan Bai Yao, a Chinese herbal drug, has been used 
as a hemostatic agent and promotes wound healing (Wu et al., 1990). Extracts of this 
medicine exhibited cytotoxic activity in several cancer cell lines. The cytotoxic component 
was later identified as the saponin formosanin-C (Ravikumar, et al. 1979). In another study, 
saponins extracted from Agave cantata and Asparagus curillus significantly inhibited the 
growth of human cervical carcinoma and leukemia cells (Sati et al., 1985). Two sapogenin 
components were identified as being responsible for inducing cytotoxicity against human 
nasopharyngeal carcinomas in culture. These saponins were extracted from the fruit of 
horsechesnuts, which has been used to treat mammary cancer (Konoshima and Lee, 1986). 
Several in vivo studies have shown that ginseng extract inhibits growth of different types of 
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tumors (Ha and Lee,1985; Kenarava et al., 1990, Lee and Huemer, 1971; Odashima et al., 
1985; Yun et al., 1983). The biological activity in ginseng is largely attributed to the 
triterpenoid saponins, or ginsenosides. Growth inhibition and reverse transformation of 
melanoma cells were observed with ginsenosides treatment (Odashima et al., 1985). 
Tubeimoside I, a triterpenoid saponin from Maxim franquet was fed to mice. A significant 
dose-dependent inhibition of edema was observed. Also, tubeimoside I was found to 
significantly decrease the number of tumor bearing mice, and the number of tumors in each 
mouse (Yu et al., 1992). In another study, saponin extracted from Gleditsiajaponica 
effectively inhibited the growth of mouse skin papilloma (Tokuda et al., 1991). Formosanin-
C, a saponin extracted from Liliaceae has been shown to have antitumor activity that acts by 
modifying the immune system (Wu et al., 1990). Mice fed with the Quillaja saponin had 
significantly higher antibody production when they were given an oral vaccination of rabies 
antigen (Maharaj et al., 1986). Sapoinin feeding reportedly enhanced cell proliferation in the 
spleen and in the lymph node (Chavali and Campbell 1987). 
In vitro, saponins were shown to form large mixed micelles with bile acids (Sidhu 
and Oakenfull, 1986). Similar interactions in vivo would reduce the free form of bile acids in 
the upper gastrointestinal tract and lowered the absorption of bile acids across the mucosa as 
well as the formation of secondary bile products from primary bile acids. Increases in the 
fecal excretion, bile acids, were observed after feeding mice diets containing 1 % soybean 
saponins (Sidhu and Oakenfull, 1986). Rao and Sung, (1995) concluded that soybean 
saponins had a dose-dependent growth inhibitory effect on human carcinoma cells and that 
viability was also significantly reduced. This study was done in culture. Koratkar et al., 
(1997) did a study on mice fed with a 3% soy saponin diet, or a control diet. The mice in the 
study were first dosed with azoxymethane, a known colon carcinogen that causes aberrant 
crypt foci. After the treatment, mice were placed on the diets. Dietary intake of soy saponins 
significantly reduced the incidence of aberrant crypt foci at the end of the trial. A study was 
done by Berhow et al., (2000) on the antimutagenic activity of soybean saponins. In the 
study, an extract was prepared from soybean molasses and fractionated into purified 
chemical components. This extract was found to contain a mixture of the group B 
soyasaponins and the DDMP soyasaponins. The extract repressed 2-
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acetoxyacetylaminofluorene induced DNA damage in Chinese hamster ovary cells. Also, a 
purified soyasaopgenol B fraction was used to demonstrate significant antigenotoxic activity 
against 2-acetoxyacetylaminofluorene. 
Cholesterol and Saponins 
Hypercholesterolemic effects of soybean saponins have been demonstrated by several 
investigators. Isolated soybean saponins reduced diet-induced hypercholesteremia in rats 
through an increase in bile acid excretion (Oakenfull et al., 1984). They also form complexes 
with bile acids and reduce their absorption in vitro (Sidhu and Oaken full 1986). Ohominami 
et al., (1981) found that when crude soyasaponins I, II, III, Al, and A2 were administered 
orally to rats with peroxidized com oil, the crude soyasaponins were found to reduce serum 
cholesterol and triglyceride. Peroxidized com oil was fed because it was found to induce 
elevation of rat serum transaminases indicating liver damage. It was also found that liver 
injury caused by peroxidized salad oil, was protected by the addition so soyasaponin Al to 
the process of peroxidation. To these studies, Calvert et al., (1981) hypothesized that 
soybean saponins, by binding bile salts in the gastrointestinal lumen, were responsible for 
some of the plasma-cholesterol-lowering effect of soybean preparations. In the study, ten 
hypercholesterolaemic men were give 50 g of soybean flour/d, containing either 22 or 4 g 
saponins/kg incorporated in biscuits. Neither diet had any effect on cholesterol in any 
plasma lipoprotein fraction, on fasting plasma triglyceride or on fecal bile acids and neutral 
sterols. These results suggested that soybean saponins are not responsible the 
hypocholesterolaemic effect of soybean products. Potter et al., (1993) conducted a study 
adding saponins to either soy protein isolate or casein based diets. When saponins were 
added to casein, blood lipid profiles were similar to those obtained from gerbils fed the soy 
protein isolate-based diets. When saponins were added to soy protein isolate, no effect was 
observed. They reported that saponins interacted chemically with soy protein very rapidly, 
forming an insoluble complex, whereas the interaction with casein was much slower. Sidhu 
et al., (1986) fed purified saponins from soapwort, soybeans and Quillaia to rats to examine 
their hypocholesterolaemic activity. They found that all the purified saponins reduced the 
rate of absorption of the bile salt; soybean and soapwort saponins substantially so, but 
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Quillaia saponin to a much lesser extent. These results were explained by the formation of 
large mixed micelles by bile acid and saponin molecules in aqueous solution. 
HIV and Saponins 
Nakashima et al., (1989) investigated soybean saponins isolate from soybean seeds 
for their antiviral activity on HIV in vitro. They found that a complex of soyasaponin V and 
I in a ratio of 1 :2, completely inhibited HIV-induced cytopathic effects and virus-specific 
antigen expression 6 days after infection. They found that a complex of soyasaponin V, I, 
and Bd from group E in a ratio of 1:2:1, inhibited HIV infection, but less potently. These 
results suggest that soybean saponins may have inhibitory activity against HIV infection. 
Liver disease and Saponins 
The antihepatotoxic activities of soyasaponin I and kaikasaponin III, isolated from 
Abrus cantoniensis were studied on liver injury induced by CC14 in primary cultured rat 
hepatocytes. Soyasaponin I showed antihepatotoxic activity equal to glycyrrhizin, the 
positive control except for the result at higher levels where the activity of soyasaponin I 
decreased. Also, compared to glycyrrhizin, soyasaponin I and kaikasaponin III were more 
toxic at the highest dose (Miyao et al., 1998). 
Taste and Flavor Chemistry of Soy 
One of the main factors limiting the increased use of soybean proteins for human 
consumption is flavor (Wilding et al., 1970). Kalbrener et al., (1971) did a sensory 
evaluation of various commercial soybean flours, soy protein concentrates, and soy protein 
isolates to determine the nature of the flavors limiting the wider use of soybean products in 
foods. The 17 member panel found 2.0% dispersions in water of the soy products to taste 
beany, bitter, chalky, and astringent. Several phenolic acids, such as syringic acid, have been 
isolated in soybeans and characterized as bitter and astringent, but their relative contribution 
to total bitterness is difficult to assess. This is because when these compounds are removed, 
the resulting product is still bitter (How et al., 1982). Other bitter components are generated 
from the oxidation of unsaturated fatty acids in both soy triglycerides and phospholipids. 
30 
Bitter hydroxyl-fatty acids are generated in the presence oflipoxygenase. A nonenzymatic 
pathway is also available to produce bitter oxo, hydroxy, ethoxy, and epoxy fatty acids 
(Sessa et al., 1977). Attempts to improve the solubility of soy protein through proteolytic 
enzyme hydrolysis have been hindered by the production of bitter peptides (Adler-Nissen et 
al., 1979). 
Bitterness 
Bitterness is commonly considered one of the four fundamental taste qualities. The 
binding of bitter compounds to receptor membranes must be slow to form and long lasting 
because the time between when a bitter compound makes contact with the tongue and the 
actual perception of bitterness can be as long as 2-7 seconds. This is a relatively slow 
response compared to other taste responses. Bitterness is often accompanied by a long 
aftertaste (Mayer et al., 1972). Numerous food and beverage products possess bitter 
substances from nature. Some of these substances include tea, coffee, cocoa, nuts, chocolate, 
beverages including beer, soft drinks, fruit and vegetable juices, ciders, wines, spirits, and 
bakery products (Roy, 1997). 
The manner in which bitterness is expressed and the compounds which are 
responsible for bitterness are exceptionally varied. Bitterness can be expressed by a wide 
range of molecules, with varying sizes and functional groups. Bitterness can be found in 
aliphatic or aromatic compounds, straight chained or polycyclic compounds, glycosides or 
aglycones with just about every functional group. Unfortunately, for the systematic study of 
bitterness, just about any type of molecule can exhibit bitterness, yet a slight structural 
modification of a bitter molecule can render it non-bitter. For this phenomena, the ability to 
predict bitterness from molecular composition is rather limited (Rouseff 1990). The research 
that has been done specifically with bitter taste and compound structure has been reviewed 
and the following generalizations can be made. Bitter taste intensity is correlated with the 
degree of molecular hydrophobicity. In bitter-tasting aqueous solutions, there is an inverse 
relationship with surface tension (Gardner et al., 1979; Pfeilsticker et al., 1978). In the case 
of amino acids, it has been shown that molecular connectivity, the total possibility of each 
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molecule to encounter another molecule in a bimolecular interaction, appears to correlate 
with bitter taste thresholds (Gardner et al., 1980). 
Objectionable Taste of Jsoflavones 
Prior to 1981, no report can be found on the relationship of isoflavones with 
objectionable flavor of soybean products. Huang et al., (1981) concluded that the 
isoflavones, the aglucon, daidzein, the ~-glucosides, genestin, and particularly glycitin 
possess a herbal-like astringency and may contribute additively to the nonvolatile 
objectionable flavor of soy protein products. The scheme used to separate these particular 
isoflavones included solvent extraction, freeze-drying, fractional crystallization, and reverse 
phase HPLC. Diadzein, genestin and glycitin were identified by ultraviolet absorption, and 
nuclear magnetic resonance spectrometry. Preliminary testing was done with a 3-person 
experienced panel. No statement was made about the experience level of the panelists. The 
water-soluble fraction was made into a 2% solution in distilled water and evaluated by the 
panelists for objectionable tastes. Water was used as a rinse before and after tasting each 
sample. Matsuura et al., (1989) reported daidzein and genistein to have an objectionable 
aftertaste. They reported that the degree of the objectionable aftertaste of soy milk increased 
with the increase in the amounts of the daidzein and genistein in the soy milk. Soy milk with 
different concentrations of daidzein and genistein were made by soaking the soybeans in 
water with and without the addition of glucono-o-lactone, which is a highly specific 
competitive inhibitor of ~-glucosidases. ~-glucosidases hydrolyze the isoflavone glucosides 
and therefore, increase the amount of daidzein and genistein. Sensory evaluation was 
performed by a 12-member experienced panel. No further statement was made about the 
experience of the panelists. Sensory evaluation was made with 20 ml of each of the five 
types of soymilk. The isoflavone content of the soymilks ranged from 0.3-1.6 mg daidzein 
per 100 ml soy milk, and 0.4-1.9 mg genistein per 100 ml of soymilk. Panelists evaluated 
each sample of soy milk on a five-point scale for objectionable aftertaste. Panelists were 
given a sugar-water solution to take away any aftertaste between samples. 
Okubo et al., (1992) reported isoflavones to be bitter by measuring first by sensory 
and second by electrophysiological methods. The isoflavones for the study were ethanol 
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extracted from ground soybeans, and the resulting residue filtered. The filtrate was 
evaporated, and the residue dissolved in methanol. The methanol solution was put on a 
Sephadex LH-20 column, eluted with methanol, fractionated, and examined by thin layer 
chromatography. First, the isoflavone solution was measured for threshold by panelists. The 
threshold value of daidzin for astringency and bitterness was lOµmol IL- lµmol IL and 
that of daidzein, its aglucon, for astringency and lingering was 1 µmol I L. The value of 
genistin (10 µmol IL) for astringency, biting, and sweet was lower than that of genistein 
(100 µmol IL) for astringency and bitterness. The threshold study concluded that the 
isoflavone aglucons were more bitter than the glucoside forms. There is no mention to the 
size or experience of the sensory panel. Second, the response intensities of isoflavone 
glucoside were done by measurements of dry mouth feel activities by the electrical response 
of the glossopharyngeal nerve of the frog. The dry mouth feel activity of genistin was 
stronger than that of the daidzin fraction, and the threshold value of genistin was also lower 
than that of daidzin. These results were not consistent with the findings of the human 
sensory test. 
Objectionable Taste ofSaponins 
Price et al., (1984) identified one of the compounds contributing to the bitter and 
astringent characteristics of some cultivars of dried pea to be soyasaponin I. In fact, the 
authors concluded that the compound possessing the undesirable taste characteristics of 
astringency and bitterness in pea is soyasaponin I. The sensory panel for this sudy consisted 
of eight trained and experienced assessors. In this experiment, the sensory panel tasted the 
soysaponin I extracts at different levels along the purification scheme. There is no mention 
of the medium used for the saponins that were tasted. First, pea flour was stirred with water, 
centrifuged, the precipitate freeze-dried, and stirred in methanol. Sensory evaluation 
established the methanol-insoluble fraction as containing the undesirable flavor 
characteristics. This fraction was then filtered, dissolved in water and subjected to reversed 
phase flash chromatography. The sensory panel found this fraction to be bitter and 
astringent. This is the last sensory evaluation done for that particular paper. The paper 
reports that further sensory analysis, which would be reported elsewhere, demonstrated very 
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similar sensory properties for the compound isolated from pea four and soyasaponin I 
isolated from soy. Further fractionation was done in the experiment to further purify the 
soyasaponin I, and analyze it. The mixture was subsequently fractionated by 
rechromatography and normal-phase flash chromatography. This saponin fraction was 
analyzed by mass spectrometry and 13C-NMR. 
Price et al, (1985) described the sensory properties of isolated soyasaponin I as bitter, 
astringent, and metallic. In this study, soyasaponin I was isolated from both pea and soy 
flours. The relationship between the concentration of soyasaponin I and sensory response 
was positively correlated. The purified saponin was assessed at a range of concentrations for 
.03-.1 % purified soyasaponin I in Malvern water. Evaluations were performed by 60 
panelists in one replication. Evaluations were performed on 5 mL samples which were 
swirled in the mouth for 10 s and expectorated. Soysaponin I was purified as in the 
previously reported by Price et al., (1984). Okubo et al. (1992) reported that soybean 
saponins, particularly saponin A contribute to the bitterness and astringency of soybeans by 
using sensory and electrophysiological methods. A 70% ethanol extract of the whole 
soybean meal was partitioned between water and n-butanol to begin saponin purification. 
The other layer was dried and dissolved in methanol. Ether was added and the precipitate 
was collected by centrifugation and further fractionated by gel filtration. A portion of each 
fraction was hydrolyzed and examined by TLC. Soybean saponins Aa, Ab, V, and I were 
isolated by preparative HPLC. Threshold was done on the soybean saponin A group. The 
values of the threshold were O.lµmol IL- 0.001 µmol IL. The taste characteristic was 
undesirable with intense bitterness. The threshold value of the soyasapongenol A aglycon 
was higher than those of saponin A group, and a similar relationship was found for other 
saponins and their aglycons. Secondly, measurements of dry mouth feel activities by the 
electrical response of the chorda tympany nerve of the rat were done. In contrast to the 
threshold information, when a measurement of dry mouth feel activity of soybean saponin A 
was doneby electrical response, there was not a membrane potential seen. It is known that 
the membrane potential change of the nueroblastoma cell is induced by bitter substances. 
From these data, it was concluded that the bitterness of soybean saponin may be different 
from those of other bitter substances. Also, when measuring dry mouth feel activities by the 
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electrical response of the chorda tympany nerve of the rat, no electrical response was found 
when adding soy saponin. Measurements of dry mouth feel activities by the electrical 
response of the glossopharyngeal nerve of the frog where done. After the application of 
soybean saponin solution to the tongue of the frog, a specific response from the 
glossopharyngeal nerve was observed. The effects of the isolated saponins Aa, Ab, V, and I 
on the intensity of the response were examined, and their threshold values measured. The 
threshold values of A group were lower than that ofB group. These results are consistent 
with the results of human organoleptic tests. Furthermore, the dry mouth feel activity caused 
by the saponin A group was more intense than that of the B group, especially at the higher 
concentration. Saponins Aa and Ab were found to have almost equivalent to the threshold 
values and response magnitude. There is no mention to the size or experience of the sensory 
panel. 
Research Objective 
The objectives of this research were to gain a better understanding of (1) soy storage 
protein :fractionation, (2) :fractionation products, (3)functionality of the fractionation 
products, and ( 4 )sensory attributes of soy isoflavones and saponins. The objective of this 
research was completed by a bench scale soy protein :fractionation study which was 
completed for three soybean varieties. The :fractions were compared for protein yield, 
composition, solubility, emulsification capacity, and isoflavone and saponin yields, and 
profiles. A separate novel :fractionation method using phytase was evaluated. A threshold 
and descriptive analysis study was done on isoflavones and saponins extracted from three 
different soy products. Threshold was measured for bitterness in water and milk. 
Descriptive analysis was done for bitterness, astringency, and off-flavor of soy isoflavones 
and saponins in water. 
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MATERIALS AND METHODS 
Project I: Sensory Characteristics of Soy Isoflavones and Soy Saponins, a Threshold 
and Descriptive Analysis Study. 
Materials 
Defatted white soy flakes were obtained from Cargill (Minneapolis, MN) in 2000. 
Soy protein isolate was produced and provided by the Center for Crops Utilization and 
Research, Iowa State University (Ames, IA). The isolate was produced in 1999. Soy germ 
was generously donated by Acatris USA, Inc., (Minneapolis, MN). The white flakes, soy 
protein isolate, and soy germ were stored at 4°C. Food grade ethanol, 200 proof, was 
purchased from Aaper Alcohol and Chemical Co., (Shelbyville, KY). HPLC grade 
acetonitrile, methanol, and trifluoroacetic acid were purchased from Fisher Scientific (Fair 
Lawn, NJ). Milli-Q system (Millipore Co., Bedford, MA) HPLC grade water was used to 
prepare all of the mobile phases for HPLC analysis. Microcrystalline cellulose NF was 
purchased from FMC Corp., (Philadelphia, PA). Food grade citrus acid and caffeine were 
purchased from Tate and Lyle (Decatur, IL). Food grade alum was purchased from Tones 
Brothers, Inc., (Ankeny, IA). Granulated sugar was purchased from United Sugars 
Corporation, (Minneapolis, MN). Sodium chloride was purchased from Mortan Inemational, 
Inc., (Chicago, IL). HyVee (Des Moines, IA) skim milk was purchased at HyVee (Ames, 
IA). The chemicals for the phosphorus analysis included hydrochloric acid, zinc oxide, 
ascorbic acid, sulfuric acid, sodium molybdate, potassium hydroxide and potassium 
dihydrogen phosphate, all from Fisher Scientific (Fair Lawn, NJ). 
Methods 
Isoflavones and saponins were extracted for a sensory study from 40 g of ground, 
defatted white flakes, 40 g of soy protein isolate, and 4 g of defatted soy germ by stirring 
each in 2 L 70% ethanol for two hours at 25°C. The extracts were filtered and dried using a 
rotary evaporator (Buchner, Brinkman, R-114, Switzerland) at 30°C. The residues were 
suspended in 100 mL of water and loaded on a C-18 High Capacity Sep-pak from the Waters 
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Corporation (Milford, Massachussets). The Sep-pak was equilibrated with deionized water, 
and fractionated with 80% ethanol. The fractions were dried in a rotary evaporator at 30°C 
and re-suspended in 100 mL of deionized water. A total of 480 g of soy flakes, 480 g of soy 
protein isolate, and 48 g of soy germ were extracted through the preceding process to obtain 
36 extracts, including 12 extracts from soy flake, 12 extracts from soy protein isolate, and 12 
extracts from soy germ. The twelve extracts within the same soy matrix were pooled to form 
on extract. All procedures were done in a food grade laboratory with food safe equipment 
and chemicals. 
To analyze for isoflavones, an aliquot of each of the 36 extracts produced was filtered 
through a 0.45-µm poly(tetrafluoroethylene) filter (Alltech Associates, Deerfield, IL) and 
analyzed by HPLC within 3 h of extraction. The HPLC method of Murphy et al (1999) was 
used to separate and quantify the individual isoflavones. Peak areas were evaluated using 
molar extinction coefficients for the 12 isoflavone forms. Soyasaponins V, I, II, ag, ~g, and 
~a were separated and quantified by HPLC using the method described by Hu, et al. (2002). 
Aliquots of each extract were measured for total phosphorus (AOAC 995.11), as a seregate 
for phospholipids. Briefly, the samples were dry ashed to remove organic material in a 
muffle furnace from Barnstead ThermoLyne 1400 (Dubuque, IA). The acid-soluble 
inorganic residue is used for color reaction based on formation of a blue complex between 
phosphate and sodium molybdate in the presence of ascorbic acid as reducing agent. 
Intensity of blue color was measured spectrophotometrically at 823 nm in a Genesys 2 
Spectrophotometer from Thermo Electon Corporation (Madison, WI). 
Panel Training 
Eleven judges from Iowa State University students and staff with previous experience 
evaluating soy products were selected on the basis of interest, availability, and ability to 
articulate sensory characteristics. A consent form identifying the project, objectives, and 
possible safety concerns was agreed to and signed by all panelists (Appendix A). Pre-
screening questionnaires for aroma and flavor were initially used to screen panelists 
(Meilgaard, et al. 1987) (Appendix B). A basic taste test and an intensity ranking test were 
used. The basic taste test included recognition of sweet, salty, bitter, sour, and astringent 
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flavors (Appendix C). A 10% solution of sucrose in water was used for the sweet standard. 
A 1.0% sodium chloride solution in water was used as the salty standard. The bitter standard 
was 0.15% caffeine in water, and the sour standard was 0.15% citric acid in water. The 
astringent standard was 0.15% alum in water. The intensity ranking test included ranking the 
previously stated flavors, each at different concentrations (Appendix D). Sucrose was 
presented at 2.0, 5.0, and 10% in water. Sodium chloride was presented as 0.2, 0.5, and 1.0% 
in water. Caffeine, citric acid, and alum were presented at 0.05, 0.08, and 0.15% in water. 
Panelists were trained for forced-choice ascending concentration series method of 
limits (ASTM E679-79) and descriptive analysis using the Flavor Profile Method (Caul, et 
al. 1957). During descriptive analysis training, panelists were given foods representing sour, 
bitter, and astringent tastes. The foods representing sour were apple cider and grapefruit 
juice. Brewed cold coffee and semisweet chocolate represented bitter flavor, and brewed 
cold tea and walnuts represented astringency. Panelists were asked to evaluate sensory 
differences among samples, and mark their response on a 10 cm intensity scale line 
(Appendix E) and discuss a list of descriptors for the samples. To train for the forced choice 
ascending concentration series method of limits, panelists ranked the bitter, astringent, and 
sour standards at three different concentrations each from least bitter, astringent, sour to most 
bitter, astringent, sour. A form similar to the form in Appendix D was used, without salty 
and sweet. Panelists used this form to evaluate the isoflavone/saponin samples at different 
concentrations and ranked the samples for intensity of bitter, astringent, sour. It was decided 
by the panelists that sour was not a flavor of the isoflavone/saponin samples. The panelists 
did notice an "off-flavor" which was described as herbal and beany for the soy flake and soy 
germ extracts. The "off-flavor" was described as plastic and cardboard for the soy protein 
isolate extract. Panelists were trained for 3 weeks in I-hour sessions 2 times a week. As 
soon as the panel was trained, sensory evaluation was conducted for 8 weeks, 2 sessions per 
week. The first six weeks consisted of the threshold study of isoflavones and saponins in 
milk and water, and the final two weeks consisted of descriptive analysis of isoflavones and 
saponins in water. 
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Bitter Threshold Evaluation of Isojlavones and Soyasaponins in Water and Milk 
A modification of the ASTM procedure E679-79 was used. Two samples, of 10 ml 
each, one water or milk reference, and one isoflavone/saponin sample in water or milk were 
presented. Five concentration levels in ascending concentration were presented per panel 
session. The extracts were presented in 3 oz. plastic cups labeled with randomly selected 3-
digit numbers. Samples were presented in partitioned booths under red light. Red lighting 
was used to mask the color difference between the extract samples and the water or milk 
samples. Panelists were provided crackers and water to rinse their mouths. Panelists 
received a rinse solution of 0.55% microcrystalline cellulose NF (MCC) suspended in water 
to remove bitter flavor (Brannan, et al. 2001). Because MCC is insoluble in water, panelists 
were instructed to mix the MCC and water before using as a rinse. Subjects were asked to 
choose the item with the most intense bitter taste, and circle the sample number with the most 
intense bitter taste (Form F). Each extract was evaluated in skim milk and de-ionized water 
in three replications. Each replication was a separate session. The individual best estimate 
threshold was calculated as the geometric mean of the last concentration of isoflavones with 
an incorrect response and the first concentration with a correct response. Group thresholds 
were calculated as the geometric mean of the individual best estimate thresholds (Vinas, et al. 
1998). Saponin concentration was calculated based on the threshold levels for isoflavone 
concentration. 
Descriptive Analysis of Jsojlavones and Soyasaponins in Water 
Three samples were used for the evaluation by descriptive analysis. The samples 
were isoflavone/saponin extracts from defatted soy flakes, soy protein isolate, and soy germ 
at 4 µmol/ml isoflavones in water. Bitterness, astringency, and "off-flavor" of the three 
extracts were evaluated in three replications. The three replications were completed during 
three separate panel sessions during three different days. Judges recorded their responses on 
separate 10-cm intensity line scales for bitterness astringency and "off-flavor". The form 
used was similar to Form E, only did not include sour. Beyond marking an intensity for the 
"off flavor", panelists were asked to name the "off-flavor" because there was no complete 
consensus of a name for the "off-flavor" taste during panel training. The 3 samples were 
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presented in 4 oz. plastic cups in a different random order for each judge during each 
replication. Water, crackers, and MCC were given to rinse the mouth as in the threshold 
panels. 
Statistical Analysis of Sensory Data 
Three replications were completed for threshold in water, threshold in milk, and 
descriptive analysis. Analysis of variance at P<0.05 (SAS Institute, Inc. 1996) was 
conducted (general linear model, PROC ANOVA) to determine the differences in bitterness, 
astringency, and off-flavor intensity for the descriptive analysis study, and the differences in 
the isoflavone profiles. 
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Project II: Altered Yield and Functionality of Glycinin and fl-conglycinin in Different 
Soybean Varieties 
Materials 
Soybeans were obtained from Cargill (Minneapolis, MN) in 2000, to be used as the 
processing control. Prolina A-1191 variety, also known as high cysteine soybeans, were 
obtained in 1999 from the North Carolina Crop Improvement Association. A Dupont 
A233HO variety, or high oleic soybeans, were obtained in 1999 from Dupont (St Louis, 
MO). The soybeans were defatted and made into flakes at the Center for Crops Utilization 
and Research at Iowa State University (Ames, IA). Flakes were stored in sealed containers at 
4 °c until use. Chemicals used in the protein fractionation methods were sodium bisulfite, 
sodium chloride, hydrochloric acid, and sodium hydroxide from Fisher Scientific (Fair Lawn, 
NJ). Crude phytase from Aspergillus ficuum was purchased from Sigma-Aldrich (St. Louis, 
MO). Additional chemicals necessary to do the urea-SDS-PAGE were urea, glycerol, 
sodium dodecyl sulfate, bromophenol blue, 40% stock acrylamide, ammonium persulfate, 
acetic acid, methanol, and glycine, purchased from Fisher Scientific (Fair Lawn, NJ). 
N,N,N' ,N' -tetramethyl-ethylenediamine was purchased from Sigma Chemicals (St. Louis, 
MO). Coomassie brilliant blue G-250 was purchased from Acros Organics (Morris 
Plains,NJ). Affinity chromotography was used to further purify glycinin and ~-conglycinin 
using Concanavalin A Sepharose 4B purchased from Sigma (St. Louis, MO). Other 
chemicals needed for purification included THAM, potassium dihydrogen phosphate, 
dipotassium hydrogen phosphate from Fisher Scientific (Fair Lawn, NJ) and methyl-a-D-
mannopyranoside, and ~-mercaptoethanol from Sigma (St. Louis, MO). Sodium azide was 
purchased from Eastman Organic Chemicals (Rochester, NY). 
For isoflavone extraction and analysis, HPLC grade acetonitrile, and methanol, were 
purchased from Fisher Scientific (Fair Lawn, NJ). For saponin analysis, HPLC grade 
trifluoroacitic acid was purchased from Fisher Scientific (Fair Lawn, NJ). Milli-Q system 
(Millipore Co., Bedford, MA) HPLC grade water was used to prepare all of the mobile 
phases. Additional chemicals for functionality tests were necessary including sodium 
potassium tartrate and copper sulfate from Fisher Scientific (Fair Lawn, NJ), and bovine 
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serum albumin and Sudan Red 7B were purchased from Sigma, (St. Louis, MO). Soybean 
oil was purchased from Sam's Club (Ames, IA). 
Methods 
Fractionation Study 
Glycinin and ~-conglycinin were fractionated according to the method reported by Wu et al 
(1999) that is a modified version ofNagano et al, (1992). In this process, 80 g of flakes were 
extracted in distilled water at 15:1 water to flake ratio at 45°C. This slurry was adjusted to 
pH 8.5 with 2N NaOH and stirred using a Fisher Scientific Isotemp Stir/Hot Plate (Fair 
Lawn, NJ) for 1 h, adjusting the pH every 15 min. The insoluble fraction was separated 
using a nylon 40 mesh (Fisher Scientific, Fair Lawn, NJ) and then by centrifugation at 9000 g 
for 30 min at room temperature using a Sorvall RC 5B Plus S centrifuge and SLA-3000 rotor 
from Sorvall Products, L.P. (Newton, CT). The supernatant was brought to 10 mM of S02 
with sodium bisulfite and the pH was adjusted to 6.4 with 2N hydrochloric acid and stored at 
4°C overnight. The glycinin was separated by centrifugation at 6500 g for 20min at 4°C. 
The supernatant was brought to 0.25 M NaCl, and the pH was adjusted to 5.0. This solution 
was stirred for 1 h on a stir plate and centrifuged at 9000 g for 30 minutes at 4°C. The 
resulting precipitate yielded an intermediate fraction composed of a mixture of glycinin, ~­
conglycinin, and other proteins. The supernatant was diluted 2-fold with distilled water and 
adjusted to pH 4.8 with 2 N hydrochloric acid. The ~-conglycinin fraction was removed by 
centrifugation at 6500 g for 20 min at 4°C. One deviation was made from the Nagano, et al. 
(1992) procedure. Nagano, et al. (1992) extracted the protein with 15-fold water at pH 7.5. 
My study was done at 15-fold water at pH 8.5 for a better protein extraction. All fractions 
were freeze dried and stored in a dessicator at room temperature. All extractions were done 
in triplicate for each flake variety. 
A separate fractionation method using phytase was evaluated using a modified 
method of Saito, et al. (2001 ). One hundred g of defatted soy flakes were stirred at pH 8.5 in 
1.5 L distilled water. The pH was adjusted with 2N sodium hydroxide every 15 min. After 1 
h of stirring, the solids were removed by a nylon 40 mesh. The liquid was centrifuged at 
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9,000 g with the SLA-3000 rotor for 30 minutes at room temperature. The precipitate was 
discarded. The supernatant was adjusted to pH 6.0 with 2 N HCl and measured for total 
protein by the biuret method (Gornall, et al 1949). An equivalent to 10 g protein of the 
supernatant was allocated into three separate beakers. Phytase was added to the supernatant 
at 0, 25, and 100 FYT phytase/1 Og soy protein. The resulting mixtures were incubated at 
40°C for 1 h. The solutions were then centrifuged at 3,500 g for ten minutes to separate the 
precipitate at room temperature. Total soluble protein by biuret was analyzed in the 
supernatant. The precipitate was the glycinin-rich fraction. Purity was evaluated for the 
glycinin-rich fraction, and the supernatant by a urea-SDS-PAGE gel electrophoresis as 
described by Wu et al. (1999). In different trials, with and without the addition of sodium 
bisulfite to achieve a 10 mM concentration of S02,and with and without a 14 h 
cryoprecipitation at 4°C were used after the phytase incubation step. This was done to 
examine effects of these modifications because the purity of the glycinin was not high as 
expected. Sodium bisulfite and cryoprecipitation were used in the modified Nagano et al. 
method. It was hypothesized that purity may rise in the phytase method upon addition of 
sodium bisulfite or a cryoprecipitation step. Total soluble protein by the biuret method and 
purity by urea-SDS-PAGE were analyzed in these samples. 
Purification of glycinin and f3-conglycin for use as standards 
Glycinin and ~-conglycinin produced by the modified Nagano fractionation process 
were further purified by affinity chromotography to use as reference standards on urea-SDS-
P AGE. Teng of the glycinin curd was dissolved in 80 ml of Wolf's buffer (potassium 
dihydrogen phosphate, di potassium hydrogen phosphate, sodium cholide, sodium azide) with 
0.78 mL ~-mercaptoethanol /L buffer. Six g of the ~-conglycinin fraction were dissolved in 
60 mL of Wolf's buffer with 0.78 mL ~-mercaptoethanol IL buffer. Both solutions were 
adjusted to pH 7.0 and stirred for 30 minutes, then centrifuged at 14,500 g with a Sorvall SA-
600 rotor for 10 minutes. The precipitates were discarded. To purify glycinin, 20 mL of the 
glycinin solution was added to the Con-A Sepharose 4B column. The column was developed 
with Wolf's buffer including ~-mercaptoethanol at 0.78 mL/L buffer. Fractions were 
collected, and the absorbence of all fractions were read at 280 nm. Any fraction with an 
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absorbance greater than 1.0 was pooled. The mg/mL soluble protein of the pooled tubes was 
measured using the biuret method. The protein was evaluated for purity on urea-SDS-PAGE. 
The purified glycinin solution can be kept at 4°C for up to one month with the addition of 
NaN3. After eluting 300 mL of the Wolf's buffer plus P-mercaptoethanol through the Con A 
Sepharose 4B column, the buffer was changed to Wolf's buffer plus 19.41 g methyl a-D-
mannopyranoside /L buffer to wash the column, or remove all ~-conglycinin left on the 
column until the absorbance of the eluting buffer returned to< 0.1. To purify ~-conglycinin, 
Wolf's buffer plus P-mercaptoethanol and 15 mL of the P-conglycinin solution was loaded 
onto the column. Fractions were collected and measured at 280 nm at until absorbance was< 
0.1. The buffer was then changed to Wolf's buffer plus methyl a-D-mannopyranoside at 
19.41 g/L buffer. Fractions were collected and the absorbance read at 280 nm. Fractions 
with an absorbance greater 0.4 were pooled and concentrated using a disc membrane 
filtration system with 50,000 dalton cut-off membrane filter (Altech Associates, Deerfield, 
IL). The solution was filtered until approximately 25 mL remained. The mg/mL 
concentration of soluble protein was measured using the biuret method. Purity was evaluated 
by urea-SDS-PAGE. The purified P-conglycinin solution can be kept in the refrigerator at 
4°C for up to 1 month with the addition ofNaN3. 
Analysis of protein Fractions of Modified Nagano Fractionation Process 
The nitrogen content of the insoluble, glycinin, intermediate, ~-conglycinin, and 
whey fractions were measured using the Nitrogen combustion method or Dumas method 
(AOAC 992.23) with a Rapid N-111 analyzer (Elemantar Americas, Inc., Mt Laurel, NJ). A 
correction factor of 6.25 was used to convert from percent nitrogen to protein (Jung et al 
2003). Moisture was determined using a forced air oven (AACC method 44-15A). Urea-
SDS-PAGE was performed using the method described by Wu et al (1999) to describe 
purity. A 25 mg protein sample was dissolved in 10 ml of protein extraction buffer (50mM 
THAM, pH 8.0, 5.0 M urea, 0.2% SDS, and 2% 2-mercaptoethanol). This protein solution 
was diluted 1: 1 with 2X sample buffer (125mM THAM, pH 6.8, 5.0 M urea, 0.2% SDS, 20% 
glycerol, and 0.01 % bromophenol blue). The column purified proteins were treated with this 
same solubilization method. Protein was loaded at 45 µg per well. An 8-18% 
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polyacrylamide gradient was used. Electrophoresis was performed at 130 V for 6 h. Gels 
were stained with a methanol/acetic acid/water (50:10:40) solution containing 0.22% 
Coomassie Blue for 5 h and then destained in the same solution without Coomassie Blue for 
20 h. Densiometry was determined using Kodak lD Image Analysis version 3.5 (Kodak, 
Rochester, NY) on scanned images produced by a Biotech Image Scanner (Amersham 
Parmacia Piscataway, NJ). SDS-PAGE results were calculated as follows. Absorbence 
values for lipoxygenase, ~-conglycinin subunits, and glycinin subunit bands were summed. 
This sum was the denominator for a corresponding numerator comprised of a sum of subunit 
bands for a given protein. When multiplied by 100, this provided a percentage composition 
for that protein with respect to the protein bands measured by densiometry analysis. 
Functionality of the glycinin, intermediate, and f3-conglycinin fractions 
The solubility of the glycinin, intermediate, and ~-conglycinin fractions from the 
modified Nagano method was measured according to a modification of a method described 
by Bian, et al. (2003). A 1 % w/w dry basis sample dispersion was prepared in deionized 
water and the pH was adjusted to 7 using 2N NaOH. The dispersions were stirred for 1 h. 
Twenty-five gram aliquots of the dispersions were portioned into 50 mL centrifuge tubes and 
centrifuged at 10,000 g on a SA-600 rotor for 10 minutes at 20°C. The supernatant was 
measured for soluble protein content using the biuret method. Solubility at pH 7.0 was 
calculated as a percent by dividing the protein in the supernatant by the initial protein content 
(determined by the Nitrogen combustion method) and multiplying by 100. Samples were run 
in triplicate. 
Emulsification capacity was measured using the method ofBian, et al. (2003). 
Twenty-five g of a 2% w/w dry basis sample dispersion adjusted to pH 7 with 2N NaOH was 
transferred to a 400 mL plastic beaker, yielding 0.5 g sample in the beaker. Soybean oil, 
containing Sudan Red 7B (Sigma, St. Louis, MO), was continuously blended into the 
dispersion at a rate of 37 ml oil/min using a Bamix wand mixer (ESGE AG Model 120, 
Mettlen, Switzerland) at the low setting until phase inversion was observed. The 
emulsification capacity (gram oil/gram sample) was calculated as g of oil used to cause 
inversion multiplied by 2. Samples were run in triplicate. 
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The HPLC method of Murphy et al. (1999) was used to separate and quantify the 
individual isoflavones. Peak areas were evaluated using molar extinction coefficients for the 
12 isoflavone forms. Soyasaponins V, I, II, ag, ~g, and ~a were separated and quantified by 
HPLC using the method described by Hu et al (2002). Isoflavones and saponins were 
extracted from all the insoluble, glycinin, intermediate, ~-conglycinin, and whey fractions of 
all three soy flake varieties, and starting defatted flake materials by stirring each in 20 mL 
acetonitrile and 14 mL distilled water for two hours at 25°C. The extracts were filtered and 
dried using a rotary evaporator (Buchner, Brinkman, R-114, Switzerland) at 30°C. The 
residues were dissolved in 10 mL of 80% methanol. An aliquot of each extract produced was 
filtered through a 0.45-µm poly(tetrafluoroethylene) filter (Alltech Associates, Deerfield, IL) 
and analyzed by HPLC within 3 h of extraction. 
Statistics of Protein Data 
All treatments were done in triplicate. Analysis of Variance (SAS Institute, Inc. 
1996) was done using the general linear model of PROC AN OVA to test the effect on 
different soy flake varieties on protein yields, purity, solublity, emulsification capacity, 
isoflavone content, isoflavone profiles, saponin content, and saponin profiles. 
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RESULTS AND DISCUSSION 
Project I: Sensory Evaluation ofisoflavones and Saponins, a Threshold and 
Descriptive Analysis Study 
The soy matrices selected for this study varied greatly from one another in their isoflavone 
form distributions (Table 1 ). This was reflected in the 70% ethanol extract concentrates of 
isoflavones, which were derived from the three soy matrices. The concentration of 
isoflavones in the soy flake extract concentrate, soy protein isolate concentrate, and soy germ 
extract concentrate were 134.6, 92.6, and 1050.4 µmol/ml, respectively. The concentrates 
contained 1 OX more isoflavones and saponins than the original extracts. This was done by 
diluting the isoflavone residue in the round bottom flask to 10 mL with water, instead of 100 
mL, which is called for in the method for isoflavone and saponin extractions and analysis. 
The soy flour extract concentrate contained predominantly malonyl-P-glucosides or about 60 
mole % isoflavone mass, about 30 mole % as the p-glucoside, and small amounts of acetyl-
P-glucosides, and aglucons (Table 1 ). Soy protein isolate extract concentrate contained 35 
mole % malonyl-P-glucosides, about 35 mole % as the p-glucoside, 20 mole % of acetyl-P-
glucosides, and approximately 12 mole% aglucons (Table 1). We see a difference in the soy 
flake and soy protein isolate profile probably due to heat and/or processing of the two 
products. The soy flour typically receives less heat processing than the soy protein isolate. 
Therefore, we see more malonyl-p-glucoside forms. (Coward, et al. 1998). Wang and 
Murphy (1996) reported that during the alkaline extraction step, in making soy protein isolate 
from soy flour, principal glycosides in the initial soy flour decreased in concentration and as 
a consequence, the soy protein isolate contained higher mole percentages of isoflavone 
aglycons compared to soy flour. Soy germ extract concentrate contained 50 mole% P-
glucosides, and 40 mole % acetyl p-glucosides (Table 1 ). The soy germ extract concentrate 
contained very small amounts of malonyl-P-glucosides and aglucons (Table 1 ). Beside 
differences in the soy matrice isoflavone distribution, there were differences between the 
three matrices in isoflavone concentration. 
The soy matrices selected for this study varied greatly from one another in their 
soyasaponin form distributions (Table 2). This was reflected in the ethanol extract 
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concentrates of soyasaponins, which were derived from the three soy matrices. The 
concentration of soyasaponin in the soy flake extract concentrate, the soy protein isolate 
extract concentrate, and the soy germ extract concentrate were 45.9, 47.3, and 331.2 
Table 1. Isoflavone profile composition of the different matrixes in mole (%) of their 
70% ethanol extracts3 
Compound 
fJ-glucosides 
Daidzin 
Glycitin 
Genis tin 
Malonyl-/3-glucosides 
Malonyldaidzin 
Malonylglycitin 
Malonylgenistin 
Acetyl-/3-glucosides 
Acetyldaidzin 
Acetylglycitin 
Acetylgenistin 
Aglucons 
Daidzein 
Glycitein 
Genistein 
TOTAL 
Total (µmol/mL) 
Flakes 
10.64a 
4.67a 
15.97a 
24.60a 
4.77a 
31.92a 
100.00 
134.60 
Isolate 
9.05a 
2.48a 
19.52b 
13.57b 
2.42b 
21.72b 
100.00 
92.60 
Germ 
28.97b 
15.86b 
7.59c 
22.ooc 
1 l.03b 
6.25c 
100.00 
1050.40 
"n = 10 (1 assay on 10 different extracts). Means in the same row with different letters are 
significantly different at p < 0.05 
µmol/ml, respectively. The soy flake extract concentrate, soy protein isolate extract 
concentrate, and the soy germ extract concentrate had very different soyasaponin form 
distributions. Soy flake extract concentrate contained almost 60% of the soyasaponin mass 
as 2,3-dihydro-2, 5-dihydroxy-6-methyl-4H-pyran-4-one (DDMP)-conjugated soyasaponins 
(Table 2). Approximately 40% of the saponins were the non-DDMP counterparts to the 
DDMP-conjugated forms. The soy flake extract concentrate was the only extract examined 
to contain more than 10% of saponins in the DDMP form. Of the DDMP forms in the soy 
flake extract concentrate, 40% were ~g. Another 16% were ~a. Soy protein isolate 
contained 90% non-DDMP forms and 10% DDMP-conjugated forms of soyasaponins (Table 
2). Of the 90% non-DDMP forms, 55% was soyasaponin I, and 25% was soyasaponin IL 
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Soy germ extract concentrate contained almost undetectable amounts ofDDMP conjugated 
soyasaponins, while containing almost 100% non-DDMP soyasaponins (Table 2). Fifty 
percent of the soyasaponins was soyasaponin I and 40% was soyasaponin V. Beside 
differences in the soy matrices soyasaponin distribution, there were differences between the 
three matrices in soyasaponin concentration. 
Table 2. Soyasaponin profile composition the different matrixes in mole (%) of their 
70% ethanol extracts8 
Compound 
Non-DDMP6 
v 
I 
II 
DDMP 
Ag 
Bg 
Ba 
Total 
Total (µmol/mL) 
Flakes 
5.63a 
20.488 
12.07a 
2.648 
42.308 
16.898 
100.00 
45.90 
Isolate 
10.llb 
54.62b 
25.12b 
100.00 
47.30 
an = 10. (1 assay on 10 different extracts) Means in the same row with different letters are 
significantly different at p < 0.05 
b DDMP = 2,3-dihydro-2,5-dihydroxy-6-methyl-4H-pyran-4-one 
Threshold study 
Germ 
39.02c 
51.18c 
2.67c 
100.00 
331.20 
Different dilutions of the concentrated solutions were prepared using water and milk 
as the medium for the threshold study. The dilutions presented to the panelists are shown in 
Table 3 for water as the medium, and Table 4 for milk as the medium. The dilutions were 
made in function of isoflavone concentration. Each concentrate solution was serially diluted. 
The concentration of saponins was calculated using the dilution factor previously applied. 
Five different concentrations of isoflavones and saponins for each extract were presented to 
each panelist at a given panel session. Evaluation of more than five different levels of 
concentrations were necessary due to the difference in tasting acuity of bitterness among the 
panelists. About half of the panelists received the extracts at the lower concentrations 
(0.004-0.064 µmol/mL), while the other half at the higher concentrations (0.128-2.048 
µmol/mL). It is known that the sensitivity to bitter taste is a heritable trait (Drewnowski et 
al., (1990). Two substances, phenylthiocarbamide (PTC) and 6-n-propylthiouracil (Prop) 
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taste bitter to some people but are tasteless to others (Fox et al., 1932). The genetically 
mediated ability to taste PTC and Prop has long been associated with enhanced sensitivity to 
other bitter compounds (Bartoshuk et al., 1980). 
The bitter threshold values obtained from the panels from the extracts in water and 
milk are listed in Table 5. The bitter threshold concentrations for isoflavones for soy flake 
extract, soy protein isolate extract, and soy germ extract in water were 0.023, 0.023, and 
0.039 µmol/ml. The saponin concentration of the soy flake extract, soy protein isolate 
Table 3. Isotlavone and saponin extract concentration used to evaluate bitter taste 
detection in water 
Ethanol Extracts 
Flake 
Isolate 
Germ 
Isoflavone Concentration 
(µmol/mL) 
0.004 
0.008 
0.016 
0.032 
0.064 
0.128 
0.256 
0.512 
1.024 
2.048 
0.004 
0.008 
0.016 
0.032 
0.064 
0.128 
0.256 
0.512 
1.024 
0.004 
0.008 
0.016 
0.032 
0.064 
0.128 
0.256 
0.512 
1.024 
Saponin Concentration 
(µmol/mL) 
0.001 
0.003 
0.006 
0.011 
0.022 
0.045 
0.090 
0.178 
0.356 
0.712 
0.002 
0.004 
0.008 
0.015 
0.031 
0.061 
0.122 
0.245 
0.490 
0.001 
0.002 
0.005 
0.010 
0.020 
0.040 
0.080 
0.156 
0.315 
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Table 4. Isoflavone and saponin extract concentrations used to evaluate bitter taste 
detection in milk 
Ethanol extracts 
Flake 
Isolate 
Germ 
Isoflavone Concentration 
(µmol/mL) 
0.064 
0.128 
0.256 
0.512 
1.024 
2.048 
4.096 
0.128 
0.256 
0.512 
1.024 
2.048 
4.096 
0.128 
0.256 
0.512 
1.024 
2.048 
4.096 
Saponin Concentration 
(µmol/mL) 
0.022 
0.045 
0.089 
0.178 
0.356 
0.712 
1.425 
0.061 
0.122 
0.245 
0.490 
0.979 
1.959 
0.040 
0.079 
0.158 
0.315 
0.630 
1.260 
Table 5. Bitter threshold concentrations of isoflavones and saponins in skim milk and 
water3 
Flakes 
Isolate 
Germ 
Isoflavones 
µmol/ml 
Water 
0.023 
0.023 
0.039 
Isoflavones 
µmol/mL 
Skim Milk 
0.338 
1.090 
0.776 
Saponins 
µmol/mL 
Water 
0.008 
0.011 
0.012 
Saponins 
µmol/ml 
Skim Milk 
0.115 
0.561 
0.225 
• Group threshold was calculated from the geometric mean of individual thresholds n= 11 panelists 
extract, and soy germ extract at the threshold for milk were 0.115, 0.561, and 0.225 µmol/ml, 
respectively. It is interesting to note that the isoflavone bitter threshold of the soy germ 
extract was almost twice as high as the soy flake extract, and soy protein isolate extract, 
indicating that the bitterness of the soy germ extract was much harder to detect. The indices 
that made the soy germ extract different from the other extracts were that its isoflavone 
profile contained a much higher percentage of the ~-glucosides, and acetyl-~-glucoside forms 
of the isoflavones. The soy germ extract contained a high percentage of soyasaponin V and a 
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low percentage of soyasaponin II in comparison to the soy flake extract and soy protein 
isolate extract. This could indicate that the bitter taste of soy does not reside in the ~­
glucoside or acetyl-~-glucoside forms of the isoflavones, or soyasaponin V of the 
soyasaponins because the soy germ contains high concentrations of these compounds, yet the 
panelists did not perceive the extracts as bitter. 
The thresholds for the three extracts in skim milk were much higher than the 
thresholds for the extracts in water, indicating that the bitterness of the extracts was less 
detectable in milk. The bitterness thresholds for isoflavones in the soy flake extract, soy 
protein isolate extract, and soy germ extract in milk were 0.338, 1.09, and 0.776 µmol/ml 
respectively, and the saponin concentrations at threshold were 0.115, 0.561, and 0.225 
µmol/ml. The bitterness thresholds for the extracts in milk are probably higher due to the 
higher protein and sugar content, and higher viscosity of milk compared to the extracts in 
water. Sugar is a commonly used masking agent for bitterants. Sweetness suppression of 
bitterness has been repeatedly demonstrated for sucrose and quinine mixtures (Bartoshuk, 
1975, Lawless, 1979), sucrose and caffeine mixtures (Pangborn, 1960) and in more complex 
systems (Guadagni et al., 1974). The magnitude of the bitterness suppression is directly 
related to the sweetness intensity. Moskowitz and Arabie (1970) observed that increasing 
solution viscosity decreased quinine bitterness intensity. Bums and Noble et al., (1985) 
found that at constant sucrose levels, perceived bitterness was reduced with increasing 
viscosity. 
The milk extract threshold results differ from the water extract threshold results in 
that the soy protein isolate extract in milk had the highest threshold value, opposite that of 
the threshold result in water. This may indicate that the malonyl-~-glucoside forms of the 
isoflavones and the non-DDMP soysaponins, particularly soyasaponin I are easily masked. 
One way these compounds may be masked is by binding to the milk protein, so that their 
bitter flavor moieties are not exposed. 
Overall, the extract from soy flakes had the lowest bitter threshold in both water and 
milk when compared to the thresholds of extract from soy protein isolate and soy germ. The 
soy flake extract contained a higher percentage isoflavones in the malonyl ~ glucoside form. 
Very interestingly, the soy flake extract contains a much higher concentration of the DDMP-
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conjugated saponins than the other two extracts. These may indicate that the bitter flavor 
originates from the malonyl-~-forms of isoflavones, and/or the DDMP-conjugated forms of 
the saponins. 
Only one other threshold study has been reported for bitterness of isoflavones and 
saponins (Okubo et al., 1992). For the isoflavone threshold study, water was used as the 
medium for isoflavones. The extracts in Okubo et al., (1992) differed from our study in that 
only one isoflavone was represented per extract. Our extracts contained all twelve soy 
isoflavones. Okubo et al., (1992) examined four different extracts by panelists for bitterness. 
The four extracts included an extract of daidzin, another of daidzein, another of genestin, and 
finally one of genistein. Okubo et al., (1992) reported that the isoflavones for the study were 
ethanol extracted from ground soybeans, and the resulting residue filtered. The filtrate was 
evaporated, and the residue dissolved in methanol. The methanol solution was loaded on a 
Sephadex LH-20 column, fractionated by elution with methanol, and examined by thin layer 
chromatography. The isoflavones were said to be in purified form. For the daidzin, 
daidzein, genistin and genestein extracts, the thresholds were reported as, daidzin at 1 OµM -
lµM, daidzein at lµM, genistin at lOµM, and genestein at lOOµM, respectively. The 
thresholds reported by Okubo et al (1992) for daidzin and genistin, both ~-glucoside forms of 
isoflavones were within range of our results. The threshold reported for daidzein was 
approximately 10-fold lower than our results, and the threshold for genestein was 10-fold 
higher than our results. Genestein and daidzein are aglucons. Our extracts had 
predominantlyhigher concentrations of ~-glucolsides than aglucons which may be a reason 
that our thresholds matched the thresholds reported by Okubu et al., (1992) for daidzin and 
genistin, and not for genestein and daidzein. 
Descriptive Analysis 
Panelists were asked to do a descriptive analysis of the soy flake extract, soy protein 
isolate extract, and the soy germ extract at 2 µmol isoflavones /ml extract in water. The 
saponin concentrations were 0. 7, 0.9, and 0.6 µmol/L for the soy flake, soy protein isolate, 
and soy germ extracts, respectively. The concentration 2 µmol/ml was chosen because it was 
much higher than the calculated bitterness threshold level and was the concentration used 
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during panel training. Panelists evaluated the extracts for bitterness, astringency, and off-
flavor by marking intensity on a 15 cm line. Panelists were asked to name the off-flavor 
noted when marking the intensity. Panelists were asked to do this because during training, 
panelists were unable to come to agreement regarding what the "off-flavor" should be 
named. The panelists noticed a different "off-flavor" for each of the extracts during training. 
The panelists used terms such as herbal, plastic, beany, cardboard, grassy, and floral to 
describe the extracts. In general, the "off-flavor" for the soy flake extract, soy protein isolate 
extract, and soy germ extract was characterized as herbal, cardboard and plastic, and beany, 
respectively during the actual panel sessions. 
The panelists found soy isolate extract to be significantly less astringent and less off-
flavored than the soy flake and soy germ extracts. Table 6 shows that panelists marked 
significantly lower intensities for the soy protein isolate extract for astringency, and off-
flavor, but not bitterness at concentrations of 2 µmol/ml each. This was an interesting 
finding because the isolate contained about 20 mole % more saponins than the soy flake 
extract, and about 30 mole% more saponin than the soy germ extract. The majority of the 
soyasaponins in the isolate extract were in the non-DDMP forms. This may demonstrate that 
soyasaponins, particularly the non-DDMP forms, do not cause the astringency and off-flavor 
of soy. The soy protein isolate extract had the highest percentage of the aglucon isoflavones, 
compared to the extracts from flakes and germ. This may indicate that the aglucon forms of 
the isoflavones have more astringent, and off-flavors. 
Table 6. Descriptive analysis on a 15cm line scale of 10 panelists on the taste of the 
water dispersed matrixes3 
Treatment Bitter Astringent Off-flavor 
Flake 5.83 
Isolate 6.53 
Germ 6.5a 
an= 10. Means in the same column with different letters are significantly different at p < 0.05 
No significant difference was found for bitterness intensity of the three extracts at the 
isoflavone concentration of 2 µmol/ml, as they were presented. In general, for the three 
extracts, the off-flavor was perceived as more intense than the bitterness or astringency of the 
extracts. 
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There are two published studies reporting on a descriptive analysis of isoflavones, 
both reporting on the off-flavor of isoflavones (Huang et al., 1981, and Matsuura et al., 
1989). Huang et al., (1981) reported that the isoflavone aglucon daidzein, and the P-
glucosides, genestin and particularly glycitin, possess a herbal-like astringency. Matsuura et 
al., (1989) reported daidzein and genistein to have an objectionable aftertaste. They reported 
that the degree of objectionable aftertaste of soymilk increased with the increase in amounts 
of daidzein and genistein in the soy milk. Interesting, the extract in our study with more 
daidzein and genistein was found by the panelists to have less off-flavor and astringency than 
extracts with less daidzein and genistein. The samples reported by Huang et al., (1981) 
probably contained more than just daidzein and genistein because they were using soymilk as 
the matrix. Soymilk contains a high concentration of glucosides (Wang and Murphy, 1996), 
however this was not considered by Huang et al., (1981). 
Two studies reported descriptive analysis of saponins (Price et al., 1984, 1985). Price 
et al., (1984) identified one of the compounds contributing to the bitter and astringent 
characteristics of some cultivars of the dried pea to be soyasaponin I. In fact, the authors 
concluded that the compound possessing the undesirable taste characteristics of astringency 
and bitterness in dry peas is soyasaponin I. Price et al., (1985) described the sensory 
properties of isoated soyasaponin I as bitter, astringent, and metallic. In their study, 
soyasaponin I was isolated from both pea and soy flours. Price et al., (1984) reported that the 
relationship between the concentration of soyasaponin I and sensory response was positively 
correlated. The purified saponin was assessed for bitterness, astringency, and metallic taste 
at range of concentrations from 0.32-1.06 µmol/g purified soyasaponin I in Malvern water or 
spring water. In our extracts, soyasaponin I was found in high concentration in the soy 
protein isolate extract and the soy germ extract. However, our descriptive analysis these two 
particular extracts did not show a tendency of more bitter or astringent characteristics than 
the soy flake extract, which has a much lower concentration of soyasaponin I. 
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Project II: A soy protein fractionation study of different soybean varieties, their 
protein yields, purities, functional properties, and isoflavone and saponin 
concentrations 
Three sources of defatted soy flakes were selected for this study. These flakes where 
from three different soybean varieties. Cargill 2000, with a PDI (protein dispersibility index) 
of 84.0, a protein content of 49.0 ± 0.7%, a concentration of total isoflavones of 6.44 µmol/g, 
and a concentration of total saponins of 5.36 µmol/g, which will be referred to as control. 
Prolina A-1191 variety from North Carolina Corp Improvement Association, that are 
documented to be high in cysteine with a PDI of 96.1, a protein content of 54.6 ± .04%, a 
concentration of total isoflavones of 5 .22 µmol/g, and a concentration of total saponins of 
5.43 µmol/g, which will be referred to as high cysteine. A233HO from Dupont Protein 
Technologies, that produce an oil that is high in oleic acid with a PDI of 62.4, a protein 
content of 53.5 ± 1 %, a concentration of total isoflavones of 6.01 µmol/g, and a concentration 
of total saponins of 3.74 µmol/g, which will be referred to as high oleic. PDI analyses were 
performed by Silliker Laboratories (Minnetonka, MN). 
The starting materials, when analyzed for original concentration of glycinin and ~­
conglycinin by urea-SDS-PAGE, the starting materials showed significant differences in 
storage protein compositions between the high oleic flakes and the other two flake varieties 
(Table 7). The oleic flakes had 10% more glycinin, and 10% less ~-conglycinin than the 
control and cysteine flakes. Figure 2 shows a urea-SDS-PAGE gel of the three flake 
varieties. The ~-conglycinin subunits of the high oleic flakes show less intense staining, 
which I interpret to mean a lower concentration of ~-conglycinin in comparison with the 
control and high cysteine flakes. Densiometry data for the SDS-PAGE gel report that the 
oleic flakes contained less total ~-conglycinin subunit concentrations than the control and 
high cysteine flakes. There were significant differences among the a, a', and ~ subunit 
concentrations of the ~-conglycinin from the three varieties. The profile for the control and 
high cysteine flakes subunit composition was similar. The control flakes had a relative 
56 
Table 7. Starting soybean flake storage protein composition %b by urea-SDS-PAGE for 
fractionation methods utilizeda 
Starting Material 
Control flakes 
High Cysteine flakes 
High Oleic flakes 
Glycinin (%) 
58.90a 
60.60a 
70.20b 
~-conglycinin (%) 
37.60a 
39.30a 
29.70b 
a n = 3. Means in the same column with different letters are significantly different at p < 0.05 
b Percentace composition of each fraction= (sum of bands corresponding to sub-units for a 
given protein)/ (sum of total bands measured) 
Figure 3. urea-SDS-PAGE of control, high cysteine, and high oleic flakes 
a' ---1111 
a .. 
1 2 3 4 5 
Lane 1 is ~-conglycinin standard, lane 2 represents the control flakes, lane 3 is 
high cysteine flakes, lane 4 is high oleic flakes, and line 5 is a glycinin standard. a', a, 
and ~ are the subunits of ~-conglycinin. A and B stands for acidic and basic subunits of 
glycinin. Amount of protein loaded to each lane was 45 µ.g. 
proportion of 30.3 ± 0.1 % a', 34.3 ± 0.1 % a, and 35.3 ± 0.1 % ~' ~-conglycinin subunit 
composition, calculated as optical density of each band divided by the sum of the bands for 
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this particular protein. The high cysteine flakes had 30.3 ± 4.1 % a', 37.9 ± 2.4 % a, and 
31.8 ± 1.8% p, P-conglycinin subunit composition calculated in the same way as for the 
control flakes. The only statistically significant difference between the control flakes and the 
high cysteine flakes was in the p subunit concentration, where the control flakes had a higher 
percentage of the p subunit, than the high cysteine flakes. For the high oleic flakes, the 
subunit profile of the P-conglycinin fraction was statistically different for each of the 
subunits with 20.6 ± 1.8 % for a', 19.9 ± 2.8 % for a, and 57.9 ± 1.3% for the p subunit, 
calculated as for the control flakes. 
A well-known and published soybean protein fractionation method was selected for 
this study, which will be referred to as modified Nagano (Wu et al., 1999). The modified 
Nagano method renders five fractions including an insoluble residue, a glycinin rich, an 
intermediate, a P-conglycinin rich, and a whey fraction (Figure 4 ). The fractionation method 
was used to produce these five fractions from the three varieties of soybeans mentioned 
before, and to compare their protein yields, purities, functional properties, and isoflavone and 
saponin concentrations. A second fractionation method, using phytase as the fractionating 
agent, was studied for yields and purities of soybean storage proteins. This method will be 
referred to as the phytase method. 
In my study the insoluble fraction consisted of 44.16 ± 0.21 % protein. The glycinin 
fraction was 98.36 ± 3.14% and the P-conglycinin fraction consisted of96.77 ± 1.03% 
protein. The intermediate fraction consisted of 82.55 ± 1.72% protein. The whey fraction 
consisted of about 16.61 ± 0.69% protein. These percentages are given for soy flakes 
obtained from Cargill in 2000, the flakes that we used as control and are reported on a dry 
basis, using N X 6.25 as the nitrogen to protein conversion factor. The protein percentages 
of the different fractions may differ in soybeans from different years, environments and 
locations, and varieties. 
Protein Yields 
Protein yield was evaluated for the insoluble, glycinin, intermediate, P-conglycinin 
and whey fractions produced in the modified Nagano fractionation process for the three 
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Figure 4. Modified Na2ano Protein Fractionation Flowchart (Wu et al 1999) 
Defatted Soy Flakes (80g) 
15XH10 l 
Adjust pH to 8.5 and stir 1 hr. Remove solids by stainless steel screen 
(40 mesh). Centrifuge at 9,000 rpm (14,300 x g) for 30 min (rt) 
NaHSO, 10 mM 
NaCl (0.25M) 
l Precipitate 
Supernatant 
... 
,, 
Adjust pH to 6.4 and store at 4°C overnight. 
Centrifuge at 6,500 rpm (7 ,500xg) for 20 min ( 4 °C) 
l 
Supernatant 
--1 
Adjust pH to 5.0 and stir 1 hr. Centrifuge at 
9,000 rpm (14,300xg) for 30 min (4°C) 
Precipitate 
l ----- Precipitate 
Supernatant 
Dilute 2X with H10 l 
Adjust pH to 4.8. Centrifuge at 6,500 
rpm (7 ,500xg) for 20 min ( 4 °C). 
l 
Whey Proteins 
Precipitate 
Insoluble 
Residue 
----- Glycinin 
Intermediate 
Mixture 
----- ~-conglycinin 
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soybean flake varieties. The mass yields of total protein of the different fractions, except for 
the insoluble and whey fractions, differed greatly among soybean varieties (Table 8). The 
control, high cysteine, and high oleic flakes yielded different total protein amounts for the 
glycinin fraction. The high oleic flakes yielded> 70% more total protein in the glycinin 
fraction than the other two varieties. The high cysteine flakes yielded significantly more 
total protein yield than the control flakes, but the yields were similar in total protein yield. 
The total protein yield for the intermediate fractions of the three different varieties were 
similar yielding approximately 5-7 g of total protein each. The total protein yields of the ~­
conglycinin fraction were different for each variety. In general, the control and high cysteine 
flakes produced> 5 fold total protein yield in the ~-conglycinin fraction. 
Table 8. Protein yield of the fractions obtained by modified Nagano method3 
Soybean flake variety and fraction Total protein yield (g) 
Starting material 
Control 
High cysteine 
High oleic 
Insoluble fraction 
Control 
High cysteine 
High oleic 
Glycinin fraction 
Control 
High cysteine 
High oleic 
Intermediate fraction 
Control 
High cysteine 
High oleic 
f3-conglycinin fraction 
Control 
High cysteine 
High oleic 
Whey fraction 
Control 
High cysteine 
High oleic 
39.24a 
43.68b 
42.80b 
12.38a 
12.76a 
12.73a 
7.18a 
9.55b 
17.13c 
6.27a,b 
6.79a 
5.64b 
5.27a 
6.89b 
0.984c 
4.95 3 
5.343 
4.91 3 
an= 3. Means in the same fraction with different letters are significantly different at p < 0.05 
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Protein Purity 
Protein purity was analyzed by urea-SDS-PAGE on the insoluble, glycinin, 
intermediate, P-conglycinin, and whey fractions produced in the modified Nagano process 
for the three soybean flake varieties. The high cysteine flakes produced significantly higher 
purities of glycinin in the glycinin-rich fraction at 91 % compared to the oleic at 78% and 
control flakes at 87% purity (Table 9). The glycinin-rich fraction purity of the control flakes 
was significantly higher than the purity of the high oleic glycinin-rich fraction. All three 
glycinin rich fraction purities were significantly different from each other. The control and 
high cysteine glycinin-rich fractions yielded similar amounts of protein and similar purities 
whereas the high oleic had much higher yield and lower purity, this might be due to the 
genetic variations or the different PDI of the starting materials. To have a better 
understanding of why these products fractionate differently we would need to start with 
materials with similar PDis so we could eliminate any additional influence beyond the 
genetic variation. The glycinin-rich fraction purity followed the PDI trend (high cysteine > 
control> high oleic). This is in accordance with what Wu et al. (1999) reported. The purity 
of the P-conglycinin in the P-conglycinin-rich fraction from the high oleic soybeans was 
19%, with the major component of this fraction being glycinin. A purity of 74% for the B-
conglycinin-rich fraction from the control flakes, and a purity of 67% for high cysteine flakes 
were observed (Table 9). All three P-conglycinin-rich fraction's composition was found to 
be significantly different. The purity of the B-conglycinin in the P-conglycinin-rich fraction 
from the control flakes was the highest at 74%, compared to the other two varieties. The 
lower yield and poor purity of the P-conglycinin-rich fraction of the high oleic flakes might 
be due to genetic variation, as the oleic flakes were the starting material with the lowest P-
conglycinin content that was mostly composed by the ~-peptide. The poor partitioning of the 
two storage proteins in this material could be due to the low PDI. The high cysteine P-
conglycinin-rich fraction yielded more protein, but with less purity than the control flakes. 
The insoluble, intermediate, and whey protein fractions were mixtures of the two storage 
proteins (Table 9). The control and high cysteine intermediate protein fractions averaged 
53% glycinin, and 38% P-conglycinin. The oleic intermediate protein fraction was different, 
consisting of 61 % glycinin, and 24% P-conglycinin. The control and oleic insoluble protein 
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fractions were 72% glycinin, while the cysteine insoluble protein fraction was 59% glycinin. 
The insoluble fraction is the only fraction where the control and high cysteine products differ 
so greatly. The control and high cysteine variety insoluble protein fractions were 37% ~­
conglycinin, and the oleic insoluble protein fraction was 23% ~-conglycinin, which can be 
explained by the lower ~-conglycinin content of the high oleic starting material. Surprisingly 
the protein yield in this fraction was the same regardless the starting material. The high 
cysteine and high oleic whey fractions averaged 72% glycinin and 16% ~-conglycinin. In 
contrast, the control whey fraction was 78% glycinin, and 13% ~-conglycinin. For all 
varieties the amount of glycinin in the whey fractions was much higher than the amount of~­
conglycinin in the whey fractions. 
Table 9. Fraction composition by urea-SDS-PAGE for purity of products for modified 
Nagano process8 
Flake variety and fraction 
Insoluble fraction 
Control 
High cysteine 
High oleic 
Glycinin fraction 
Control 
High cysteine 
High oleic 
Intermediate fraction 
Control 
High cysteine 
High oleic 
f3-conglycinin fraction 
Control 
High cysteine 
High oleic 
Whey fraction 
Glycinin (%of protein) 
72.063 
59.46b 
71.463 
87.043 
90.73b 
78.24c 
52.45 3 
54.073 
61.53b 
23.11 a 
33.21 b 
69.48c 
~-conglycinin (% of protein) 
37.81 a 
36.403 
23.01 b 
12.963 
9.26b 
21.76c 
38.893 
38.653 
24.31b 
74.383 
66.79b 
19.31c 
Control 78.623 12. 763 
High cysteine 71.35b 16.89b 
High oleic 72.13 b 16.21 b 
3 n = 3. Means in the same fraction with different letters are significantly different at p < 0.05 
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Phytase Fractionation 
Phytase was used to fractionate glycinin and ~-conglycinin from the Cargill control 
flakes using the method described by Saito et al., (2001). The phytase fractionation scheme 
can be seen in Figure 5. First, a trial study was done by adding different concentrations of 
phytase at 0, 250, and 1000 FTY/100 g of soy protein, according to Saito et al., (2001), to 
determine how much protein was precipitated at the different phytase concentrations. FTY is 
an enzyme activity unit that is defined as the amount of enzyme that releases 1 µmol of 
inorganic orthophosphate per minute at pH 5.5, 37 °C and 5 mM sodium phytate (Saito et al., 
2001 ). The addition of phytase was done after alkali extraction and centrifugation of the 
insoluble fiber-rich residue, as can be seen in Figure 5. The trial study was important to 
Figure 5. Modified phytase method flowchart (Saito et al 2001) 
Defatted soy flakes 
Precipitate Supernatant 
Precipitate Supernatant 
Glycinin ~-conglycinin 
rich fraction rich fraction 
Extract with 15-fold volume of 
water at pH 8.5 and room 
temperature. Centrifuge at 
14,300 x g for 30 min 
Adjust pH to 6.0 with HCl. 
Add phytase (varied FYT). 
Incubate for lh at 40°C. 
Optional cooling at 4 'C, or 
addition ofNaHS03 at JO mM 
Centrifuge at 3,000 x g for 10 
min at room temperature 
determme 1t the experiment described by Saito et al., (2001) was reproducible. The amounts 
of protein precipitated obtained were significantly higher than those obtained by Saito and 
are shown in Table 10. With no phytase present, 39.2 % of the total proteins in the protein 
extract were precipitated. At 250 and 1000 FTY phytase, 47% and 65% of total proteins 
were precipitated, respectively. For the same phytase concentrations, Saito et al (2001) 
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reports a protein precipitation of 27% with no phytase addition, and 55% protein precipitated 
for 1000 FYT. These differences would suggest that the type and quality of starting material 
and/or enzyme used were not the same. My second approach for the phytase method was to 
chill the protein extract after addition and incubation with phytase, since glycinin is known to 
be insoluble at refrigeration temperatures, 10% more protein was precipitated from the 
protein extract containing a concentration of250 FTY phytase. My third approach was to 
add sodium bisulfite after the addition and incubation with phytase. The same result was 
observed as with the chilling process (Table 10). Chilling or adding sodium bisulfite had no 
Table 10. Yield of protein in precipitate for phytase method (protein precipitated, % )a 
Phytase added 
(FTY /1 OOg protein) 
OFTY 
250 FTY 
1000 FTY 
Phytase method Phytase and chilling 
42.0a 
58.0c 
64.0c,d 
an= 3. Means with different letters are significantly different at p < 0.05 
FTY = phytase activity units. 
Phytase and sodium 
bisulfite 
44.0a 
60.0c 
66.0d 
Table 11. Protein fraction composition for phytase treatment by urea-SDS-PAGE 
Treatment and Fraction Glycinin (%of protein) ~-conglycinin (%of protein) 
Precipitate 
Control 77.6a 18.5a 
250 FYT 70.6b 24.0b 
1000 FYT 68.8b 27.8b 
250 FYT and chilling 65.7c 34.3c 
1000 FYT and chilling 59.2d 35.3c 
250 FYT and bisulfite 64.5c 30.ld 
1000 FYT and bisulfite 60.8d 33.6c,d 
Supernatant 
Control 61.3a 34.4a 
250 FYT 62.0a 34.3a 
1000 FYT 42.9b 49.7b 
250 FYT and chilling 18.3c 71.2c 
1000 FYT and chilling 15.0d 72.7c 
250 FYT and bisulfite 16.8c,d 73.9c 
1000 FYT and bisulfite 17.4c 73.5c 
an = 3. Means in the same fraction and for each storage protein, with different letters are significantly 
different at p < 0.05 
FTY = phytase activity units. 
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statistically significant effect on the percentage of protein precipitated in either the protein 
extract that had no enzyme added or the protein extract that was treated with 1000 FTY. As 
seen in the Table 10, the addition of 1000 FTY alone precipitated the highest percentage of 
protein. This is an improvement upon the modified Nagano method which requires a 
chilling step and addition of sodium bisulfite. Another benefit of the phytase method is that 
it does not produce an intermediate fraction. However, these protein yielding benefits, had 
negative purity implications. The results of purity analyzed by urea-SDS-PAGE are shown 
in Table 11. The elimination of the intermediate fraction causes a decrease in purity. 
Figure 6a. U rea-SDS-P AGE of phytase method supernatants and precipitates 
1 2 3 4 5 6 7 
a'---• 
a .. 
~J A 
Lane 1 represents ~-conglycinin standard, lane 2 is the supernatant resulting from the 
control (no phytase addition), lane 3 is the precipitate from the control, lane 4 is the 
supernatant from 250 FYT treatment, lane 5 is the precipitate from 250 FYT treatment, lane 
6 is the supernatant from the 1000 FYT treatment, and lane 7 is the precipitate from the 1000 
FYT treatment. a', a, and~ are the subunits of ~-conglycinin. A and B stands for acidic and 
basic subunits of glycinin. Each lane was loaded with 45 µg of protein. 
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Figure 6b. Urea-SDS-PAGE of modifications of the phytase method supernatants and 
precipitates 
1 2 3 4 5 6 7 8 9 10 ex' 
B 
Lane 1 is the precipitate from 250 FYT and 4 °C treatment, lane 2 is the 
precipitate from the 1000 FYT and 4 °C treatment, lane 3 is the precipitate from 250 FYT 
and lOmM NaHS03 treatment, lane 4 is the precipitate from 1000 FYT and lOmM NaHS03 
treatment, lane 5 is the supernatant from 250 FYT and 4°C treatment, lane 6 is the 
supernatant from 1000 FYT and 4 °C treatment, lane 7 is the supernatant from 250 FYT and 
lOmM NaHS03 treatment, lane 8 is the supernatant from the 1000 FYT and lOmM NaHS03 
treatment, lane 9 is ~-conglycinin standard, and lane 10 is glycinin standard. a', a, and~ are 
the subunits of ~-conglycinin. A and B stands for acidic and basic subunits of glycinin. Each 
lane was loaded with 45 µg of protein. 
The purity results for the precipitate or glycinin-rich fraction at 250 FTY and 1000 
FTY were 70 and 68% glycinin, respectively. With addition of chilling, the glycinin-rich 
fraction purity at 250 FTY and 1000 FTY decreased to 65 and 60% glycinin, respectively. 
Similar results were observed with addition of sodium bisulfite. However, the supernatant, 
or ~-conglycinin-rich fraction, showed a statistically significant difference by adding a 
chilling step, or by addition of sodium bisulfite. Without these extra steps, the ~-
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conglycinin-rich fraction was 34-40% P-conglycinin, depending on the concentration of 
phytase added. With either chilling, or sodium bisulfite addition, the percent P-conglycinin 
increased to more than 70% in the P-conglycinin-rich fraction, suggesting an obvious 
improvement from the former. This method seems to be useful to produce glycinin and P-
conglycinin enriched fractions, but purities may depend on the quality of the enzyme and 
starting material in addition to a rigorous process control. 
Functional properties 
Functional properties are the basis for the industrial utilization of soybean protein 
ingredients in the food industry. The future use and applicability of the products in this study 
will depend on their functional properties. The functional properties tested in this study were 
solubility and emulsification capacity. The principal functional property that will determine 
the use of a functional food ingredient, such as any of these soy protein fractionation 
products, will be the product's solubility. This functional property is defined as the most 
important by several authors (Kinsella, 1979, 1985, Kalbrener et al., 1971, Saio, et al., 1969) 
and it is also suggested in these studies to be the functional property that might predict the 
behavior of an ingredient in a given food system. Emulsification capacity is other very 
important functional property of food ingredients. This functional property tests the ability 
of a food ingredient to act in water/oil interfaces. The ability of emulsifying oil will 
determine the usefulness of these ingredients in water/oil food systems such as salad 
dressings and mayonnaise. 
Solubility 
Liu et al., (1997) and Wolf (1970) recommended the use oflow solubility soy protein 
for beverages and bakery products such as crackers and cereals, and high solubility for 
foamed and gelled products. When incorporated into food and beverage, soy protein must 
form stable dispersions. A stable dispersion is usually correlated to proteins with good 
solubility (Wang and Johnson, 2001). 
In my study, the protein solubility was evaluated at pH 7.0 for the glycinin, 
intermediate, and P-conglycinin fractions. The results of this functional property test can be 
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seen in Table 12. The pH 7 was selected because isolated soy proteinates are sold after being 
neutralized. Solubility was not analyzed for the oleic P-conglycinin fraction because there 
was not enough sample. In general, the glycinin fractions and the P-conglycinin fractions 
have high solubilities because these proteins are in native state (Wu et al., 1999). The more 
denatured proteins, found in the intermediate fractions, are less soluble (Wu et al., 1999). 
The control glycinin, intermediate and P-conglycinin fractions all had higher solubilities than 
these :fractions from the high cysteine and high oleic flakes (Table 12). The high oleic flakes 
registered the lowest solubilities for each of the fractions tested. This might be a reflection of 
the PDI of the flakes which is the lowest for the three flake varieties tested. The high 
cysteine fractions were consistently lower in solubility when compared to the control 
fractions. This cannot be due to the PDI, since the PDI of the control flakes was lower that 
that of the high cysteine flakes. These differences could be due to genetic variation of the 
two flake varieties or because there are differences in purities of fractions tested in this study. 
Table 12. Solubility of modified Nagano process protein fractionsa 
Flake variety and :fraction Solubility (%) 
Glycinin fraction 
Control 
High cysteine 
High oleic 
Intermediate fraction 
Control 
High cysteine 
High oleic 
P-conglycinin fraction 
94.52a 
84.15b 
78.llc 
48.22a 
38.44b 
35.53b 
Control 82. 72a 
High cysteine 63.25b 
High oleic N/ A 
an= 3. Means in the same fraction with different letters are significantly different at p < 0.05 
It was not unexpected to see such different results in different flake varieties and 
different fractionation products. Storage protein composition of soybeans, that is glycinin to 
P-conglycinin ratios, and native state conformation are responsible for protein product 
functionality (Petruccelli et al., 1995). This is in accordance with Kwanyuen et al., (1998) in 
that compositional differences that may alter functionality include the ratio of storage 
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proteins, and variations in subunit concentrations within these individual storage proteins. 
Influences in functional properties might be determined by differences in amino acid profiles 
(Serretti et al., 1994 ). 
Emulsification Capacity 
The ability of protein to aid the formation and stabilization of water and oil emulsions is 
necessary for many food applications. In food products, such as comminuted meats, cake 
batters, milks, and salad dressings, varying emulsifying capacities are required due to the 
differing composition and stresses to which the products are subjected (Kinsella, 1979). In 
my study, emulsification capacity was evaluated for the glycinin, intermediate and P-
conglycinin fractions of all three varieties. Emulsification capacity was not done on the oleic 
P-conglycinin fraction because not enough of that fraction was available. The emulsification 
capacity of the glycinin was quite different than the emulsification capacity of P-conglycinin 
for all varieties (Table 13). The glycinin-rich fraction emulsification capacity for all flake 
Table 13. Emulsification Capacity of modified Nagano process protein fractions8 
Flake variety and fraction Emulsification Capacity (g oil/g product) 
Glycinin .fraction 
Control 
High cysteine 
High oleic 
Intermediate .fraction 
Control 
High cysteine 
High oleic 
~conglycinin .fraction 
Control 
High cysteine 
High oleic 
an= 3. Means in the same fraction with different letters are significantly different at p < 0.05 
varieties was significantly lower than the emulsification capacity of the P-conglycinin-rich 
fraction. This finding is in accordance with Yamaguchi et al., (1991) that P-conglycinin has 
shown to possess greater emulsifying properties than glycinin, probably due to that it is a 
more hydrophobic protein when compared to glycinin. Control P-conglycinin had a much 
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larger emulsification capacity than the high cysteine ~-conglycinin. The high oleic flake 
glycinin fraction showed better emulsifying capacity compared to the glycinin fractions of 
the other two varieties, possibly due to its lower purity. The high oleic variety had about 
10% less glycinin in its glycinin-rich fraction, and a higher percentage of ~-conglycinin than 
the other two varieties tested in this study. Unfortunately, there was not enough sample for 
testing emulsification capacity on the ~-conglycinin-rich fraction of the high oleic flakes. 
The high oleic intermediate fraction showed a significantly better emulsifying capacity 
compared to the intermediate fractions of the other two varieties. This observation is 
interesting because all of the intermediate fractions from the different varieties have similar 
glycinin and ~-conglycinin profiles and protein yields. The better emulsification capacity on 
the high oleic intermediate fraction may be do to the low PDI of the high oleic flakes. A low 
PDI is associated with higher denaturation that, would in tum, result in a higher surface 
hydrophobicity because of unfolding of the proteins, thus improving the emulsification 
capacity (Kinsella 1979). 
Jsoflavones 
In this study, isoflavones were quantified for the insoluble, glycinin, intermediate, ~­
conglycinin, and whey fractions. Isoflavones were not measured in the high oleic ~­
conglycinin fraction because there was not enough ~-conglycinin produced from the high 
oleic flakes to measure isoflavones. In this study, in general, the control flakes contained a 
significantly higher concentration of isoflavones at 6.44 µmol/g than the high cysteine flakes 
at 5.23 µmol/g and the high oleic flakes at 6.0lµmol/g. High concentrations of isoflavones 
were found in the glycinin fractions compared to the B-conglycinin fractions (Table 14). The 
highest concentration of isoflavones was found in the intermediate fractions of all flakes. 
The cysteine intermediate fraction contained a significantly lower concentration of 
isoflavones than the intermediate fraction of the oleic and control intermediate fraction. The 
mass yield of isoflavones for the control, high oleic, and high cysteine beans were 374, 398, 
and 389 µmoles, respectively. 
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Table 14. Total isotlavone contents of modified Nagano process protein fractions3 
Flake variety and fraction 
Starting material 
Control 
High cysteine 
High oleic 
Insoluble fraction 
Control 
High cysteine 
High oleic 
Glycinin fraction 
Control 
High cysteine 
High oleic 
Intermediate fraction 
Control 
High cysteine 
High oleic 
~conglycinin fraction 
Control 
High cysteine 
High oleic 
Whey fraction 
Control 
High cysteine 
High oleic 
Total Isoflavones (µmol/g) 
6.44a 
5.23b 
6.0lc 
3.83a 
3.41 b 
3.88a 
7.04a 
6.27b 
6.41 a,b 
l l.59a 
9.93b 
l l.42a 
2.46a 
l.94a 
NIA 
an= 3. Means in the same fraction with different letters are significantly different at p < 0.05 
Rickert et al., (2003) reported similar isoflavone concentrations for the insoluble, 
glycinin, intermediate, ~-conglycinin, and whey fractions. The isoflavone concentrations in 
the Rickert et al., (2003) study were reported slightly higher in all fractions than the 
isoflavone concentrations in my study, but follow the same trend as my concentration values. 
We both find the intermediate fraction to have the highest concentration of isoflavones 
(µmol/g, dry basis), followed by the glycinin, insoluble and whey fractions, and the lowest 
concentration of isoflavones found in the ~-conglycinin fractions. I would expect to have 
similar results as Rickert et al., (2003) for the control flakes because both studies used the 
Cargill 2000 flakes as the starting material 
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Table 15. Isoflavone profile of fractionation products for modified Nagano process 
(µmol/g).3 
Product 
Starting Flakes 
/3-glucosides 
Daidzin 
Glycitin 
Genistin 
Malonyl- f3-glucosides 
Malonyldaidzin 
Malonylglycitin 
Malonylgenistin 
Acetyl-f3-glucosides 
Acetyldaidzin 
Acetylglycitin 
Acetylgenistin 
Aglucons 
Daidzein 
Glycitein 
Genistein 
Insoluble residue 
f3-glucosides 
Daidzin 
Glycitin 
Genistin 
Malonyl-/3-glucosides 
Malonyldaidzin 
Malonylglycitin 
Malonylgenistin 
Acetyl-/3-glucosides 
Acetyldaidzin 
Acetylglycitin 
Acetylgenistin 
Aglucons 
Daidzein 
Glycitein 
Genistein 
Control 
0.49a 
0.15a 
0.73a 
0.74a 
0.12a 
0.90a 
O.Ola 
0.06a 
0.03a 
o.21a,b 
o.osa 
0.32a 
High Cysteine 
0.06a 
0.09a 
0.11 a 
0.45a 
0.19a 
0.95b 
0.45b 
0.16a 
0.80a 
O.Ola 
o.02a 
0.03a 
0.11 a 
o.osa 
o.21a 
High Oleic 
0.6lb 
o.22a 
0.99b 
0.34b 
O.lOa 
0.47b 
O.Ola 
o.02a 
0.03a 
0.34b 
0.09a 
0.66b 
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Table 15. Continued 
Product Control High Cysteine High Oleic 
Glycinin rich fraction 
f3-glucosides 
Daidzin 0.06a 0.05a 0.04a 
Glycitin 0.05a 0.31b o.02a 
Genis tin 0.15a 0.16a O.lOa 
Malonyl-/3-glucosides 
Malonyldaidzin l.47a 0.72b 0.70b 
Malonylglycitin 0.23a 0.23a 0.17a 
Malonylgenistin 2.72a 2.18b l.35c 
Acetyl-/3-glucosides 
Acetyldaidzin 0.07a 0.04a O.Olb 
Acetylglycitin 0.03a 0.15b o.02a 
Acetylgenistin O.l 7a o.12a 0.03b 
Aglucons 
Daidzein 0.75a 0.64a 1.25b 
Glycitein o.2oa 0.25a 0.37b 
Genistein l.14a 1.41 b 2.37c 
Intermediate fraction 
/3-glucosides 
Daidzin 0.39a 0.23b 0.43a 
Glycitin 0.16a 0.16a 0.24b 
Genis tin 0.98a 0.86a l.16b 
Malonyl-/3-glucosides 
Malonyldaidzin 2.18a 0.99b 0.74b 
Malonylglycitin 0.32a 0.30a 0.21b 
Malonylgenistin 3.70a 2.54b l.47c 
Acetyl-/3-glucosides 
Acetyldaidzin 0.06a O.Olb O.Olb 
Acetylglycitin 0.08a 0.31 b 0.16a,b 
Acetylgenistin 0.13a 0.07b 0.03b 
Aglucons 
Daidzein l.38a 1.30a 2.27b 
Glycitein 0.23a 0.34a,b 0.48b 
Genistein l.99a 2.8lb 4.21 c 
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Table 15. Continued 
Product Control High Cysteine High Oleic 
P-conglycinin fraction 
P-glucosides 
Daidzin 0.033 0.043 NIA 
Glycitin 0.023 0.043 NIA 
Genistin 0.153 0.113 NIA 
Malonyl-P-glucosides 
Malonyldaidzin 0.443 0.16b NIA 
Malonylglycitin 0.073 0.063 NIA 
Malonylgenistin 0.663 0.35b NIA 
Acetyl-P-glucosides 
Acetyldaidzin 0.023 0.013 NIA 
Acetylglycitin 0.023 0.063 NIA 
Acetylgenistin 0.033 0.033 NIA 
Aglucons 
Daidzein 0.373 0.323 NIA 
Glycitein 0.063 0.023 NIA 
Genistein 0.593 0.75b NIA 
Whey 
P-glucosides 
0.363,b 0.45b Daidzin 0.303 
Glycitin 0.153 0.213.b 0.25b 
Genis tin 0.363 0.393'b 0.443,b 
Malonyl-P-glucosides 
l.13b Malonyldaidzin 1.373 0.63c 
Malonylglycitin 0.203 0.37b 0.173 
Malonylgenistin 1.023 l.22b 0.543 
Acetyl-P-glucosides 
O.llb Acetyldaidzin 0.013 0.013 
Acetylglycitin 0.023 0.12b 0.023 
Acetylgenistin 0.033 0.06b 0.033 
Aglucons 
Daidzein 0.183 0.26b 0.43c 
Glycitein 0.023 0.04b 0.023 
Genistein 0.133 0.28b 0.37c 
an= 3. Means in the same row with different letters are significantly different at p < 0.05 
Among the insoluble, glycinin, intermediate, ~-conglycinin, and whey fractions, the 
Malonyl-~-glucosides predominate for all flake varieties (Table 15). Malonyl forms 
predominate in less processed soy products (Wang and Murphy, 1994). In my study, there 
was one exception, the intermediate fraction of the high oleic and high cysteine flakes, where 
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the aglucons predominate. Coward et al., (1998) reported that a rise in aglucon concentration 
was seen in foods receiving higher heat treatment when compared to foods with less heat 
treatment. The high oleic flakes did have a higher concentration of aglucons measured in the 
starting material. We know that the high oleic flakes have a lower PDI than the two other 
varieties and probably received more heat treatment, this could be a possible factor in the 
higher concentration of aglucons measured in the high oleic flakes. The date in Table 15, it 
is notable that all flake varieties have a higher concentration of aglucons in their intermediate 
fractions, than any other fractions. This is probably due to the intermediate fraction having 
the highest concentration of total isoflavones of all the fractions. 
Saponins 
In this study, saponins were quantified in the insoluble, glycinin, intermediate,~­
conglycinin, and whey fractions. Saponins were not measured in the high oleic ~­
conglycinin fraction because there was not enough ~-conglycinin product to do the 
extraction. In general, the saponin concentration in the control, cysteine, and oleic flakes was 
5.48, 5.46, and 3. 74 umol/g, respectively. In contrast with isoflavones, saponins were found 
in higher concentrations in the B-conglycinin fractions of the process (Table 16), but at 
highest concentrations in the intermediate fractions. The mass yield of saponins for the 
control, high oleic, and high cysteine beans were 362, 209, and 319 µmoles, respectively. 
The smaller mass yield of saponins from the high oleic flakes is reflected in the intermediate 
fraction, where the high oleic intermediate fraction had about a 40% decreased concentration 
of saponinins when compared to the control and high cysteine intermediate fractions. 
My results compare well with results from Rickert et al., (2003), except for concentration of 
total saponin in the ~-conglycinin fraction. My results were higher, making the~­
conglycinin fraction a richer source of saponins than the glycinin fraction. Rickert et al., 
(2003) showed the glycinin and ~-conglycinin fractions to be similar in total saponin 
concentration. The data from the two studies did reflect that saponin concentration is the 
highest in the intermediate fraction, then the insoluble, glycinin and ~-conglycinin fractions, 
and there are almost undetectable amounts of saponins in the whey fraction. 
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Table 16. Total saponin contents of modified Nagano process protein fractions8 
Flake variety and fraction 
Insoluble fraction 
Control 
High cysteine 
High oleic 
Glycinin fraction 
Control 
High cysteine 
High oleic 
Intermediate fraction 
Control 
High cysteine 
High oleic 
fJ-conglycinin fraction 
Control 
High cysteine 
High oleic 
Whey fraction 
Total Saponins (µmol/g) 
0.782a 
1.38b 
1.42b 
15.31a 
15.29a 
9.30b 
3.56a 
3.17a 
NIA 
Control 0.295a 
High cysteine 0.425b 
High oleic 0.371 b 
an= 3. Means in the same fraction with different letters are significantly different at p < 0.05 
Saponin I and its DDMP-form conjugate ~g are the most prevalent saponins 
measured in most of the fractions for all three varieties as shown in Table 17. Hu, et al. 
(2002) measured soysaponins V, I, II, ag, ~g, and pa in foods on a µmol/g basis, and 
reported saponins I and ~g to be the most prevalent saponins in soy products such as soybean 
flour, tofu, tempeh, soymilk, and soy protein isolate. 
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Table 17. Saponin profile of fractionation products for modified Nagano process 
(µmollg).8 
Product Control High Cysteine High Oleic 
Starting Flakes 
Non-DDMPb 
v 0.2328 0.3948 0.4278 
I 1.2308 0.41lb 0.724c 
II 0.351 8 0.563a,b 0.745b 
DDMP 
Ag 0.1908 0.1998 0.1268 
Bg 2.7608 2.9548 1.38lb 
Ba 0.891 a 1.237b 0.448c 
Insoluble residue 
Non-DDMPb 
v 0.3368 0.2308 0.4838 
I 2.8048 2.7138 0.917b 
II 1.571 a 1.937a 0.808b 
DDMP 
Ag 0.1728 0.061 8 0.128a 
Bg 1.8758 0.974b l.156c 
Ba 0.701 a 0.4068 0.3228 
Glycinin fraction 
Non-DDMPb 
v 0.2558 0.262a 0.2998 
I 0.2708 0.613b 0.504a,b 
II 0.0878 0.307a 0.2188 
DDMP 
Ag 0.011 8 0.0378 0.0378 
Bg 0.0678 0.151 a 0.2428 
Ba 0.0938 O.Olla 0.121 a 
Intermediate fraction 
Non-DDMPb 
v 1.0478 0.669b 0.519b 
I 5.803a 6.989b 2.813c 
II 2.6358 3.48lb 0.951c 
DDMP 
Ag 0.2668 O. l 75a 0.2758 
Bg 3.9958 3.072b 3.652a 
Ba l.564a 0.904b 1.102b 
77 
Table 17. Continued 
/J-conglycinin fraction 
Non-DDMPb 
v 0.344a 0.360a NIA 
I 1.254a 0.971 a NIA 
II 0.828a 0.886a NIA 
DDMP 
Ag 0.078a 0.073a NIA 
Bg 0.717a 0.593a NIA 
Ba 0.343a 0.829b NIA 
Whey 
Non-DDMPb 
v 0.183a o.112a 0.242a 
I o.oooa 0.094b o.oooa 
II 0.037a 0.015a 0.069a 
DDMP 
Ag 0.026a O.Ol 7a 0.032a 
Bg o.oooa 0.041b o.oooa 
Ba 0.049a 0.052a 0.036a 
3 n = 3. Means in the same row with different letters are significantly different at p < 0.05 
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GENERAL CONCLUSIONS 
A threshold and descriptive analysis sensory evaluation were completed for bitterness 
of isoflavones and saponins. From the results, it can be concluded that the DDMP-
conjugated saponins and the malonyl-~-glucoside isoflavones have more off-flavor and/or 
are more bitter than other saponins and isoflavones found in soy. Furthermore, it would 
seem that less processed or heat treated soy products would have more off flavor or bitter 
flavor caused by isoflavones and saponins. 
Further work could be done to look at saponins or isoflavones individually and 
assessing them to bitter flavor. There is a need for threshold values for other suspected off-
flavor components in soy, so that our bitter thresholds can be compared to other bitter 
compounds. 
The modified Nagano fractionation method was successfully executed at bench scale 
for three soybean varieties, and several conclusions can be drawn out of my findings. First, 
the genetic background and thermal history of the starting materials significantly influences 
protein partitioning during this process, protein purity, functionality of fractions, and 
isoflavone and saponin content and distribution. Further studies are to be conducted since 
very little is known about the behavior of different genetically modified soybeans during 
processing. If there would be an interest in producing these protein fractions on a larger 
scale, I would recommend the high cysteine flakes as a starting material. The high oleic 
flakes are not recommended for this fractionation process if significant amounts of a ~­
conglycinin enriched fraction are desired. A second problem encountered is that these flakes 
were difficult to centrifuge since they did not give a compact curd that allows an effective 
separation. As new varieties become available, it would be a good idea to fractionate them 
on lab scale, now that we know different varieties behave differently in the same process. 
The phytase method seems promising, but further development is needed to better 
understand which is the mechanism of action and if different flakes with different phytic acid 
contents can be treated in the same way. I do not recommend immediate scaling up of this 
process, since it requires energy intensive steps of incubation and cooling that would be 
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economically impractical at this stage. The use of enzymes is a drawback for considering 
this process suitable for industrial purposes. 
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APPENDIX A 
INFORMED CONSENT 
Novel Approaches to New Soybean Protein Ingredients with Enhanced Health Benefits 
October 2002 
This research is being conducted by Dr. Patricia Murphy and Dr. Cheryll Reitmeier, 
Department of Food Science and Human Nutrition, Iowa State University. The evaluation 
involves the sensory evaluation of soy protein products containing isoflavones and saponins. 
These compounds may be of benefit nutritionally, but are bitter and astringent. The objective 
of this work is to determine the flavor thresholds for isolated soy isoflavones and saponins. 
Panelists will be asked to evaluate solutions containing various concentrations of soy 
compounds as well as foods containing the soy protein products. 
The soy protein fractions were produced in the processing facility of the Center for 
Crops Utilization Research, ISU, under Good Manufacturing Practices. The protein and 
fractions are of food-grade quality. Samples for sensory evaluation will be prepared in the 
Test Kitchen, 2951 FSB, ISU, under sanitary conditions. 
Panelists will be screened for soy allergies and not allowed to participate if allergic. 
Panelists will be trained in 6 hourly sessions to recognize bitter and astringent flavor 
characteristics. Training is tentatively scheduled for October and November 2002, with 
evaluation sessions to begin in November 2002. Panelists will evaluate 3 solutions of 
samples at each of 12 sessions. 
Responses to the sensory evaluation will be used only in coded statistical analysis 
without reference to the respondent. Benefits include a reward of food at each session, a gift 
of $20.00 at the end of the sessions, and a significant contribution to improving the health 
benefits of soy foods. Dr. Reitmeier (294-4325) will be available throughout the study to 
answer questions associated with the evaluation. 
Emergency treatment of any injuries that may occur as a direct result of participation 
in this research is available at the Iowa State University Student Health Services, and/or 
referred to Mary Greenley Hospital or another physician or medical facility at the location of 
the research activity. Compensation for any injuries will be paid if it is determined under the 
Iowa Tory Claims Act, Chapter 669 Iowa Code. Claims for compensation should be 
submitted on approved forms to the State Appeals Board and are available from the Iowa 
State University Office of Risk Management and Insurance. 
*** I understand the research being conducted and agree to evaluate soy protein 
products. I understand that I should be present for all evaluation sessions. I 
understand that I can withdraw at any time. I will notify the investigator if I can no 
longer participate. *** 
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APPENDIXB 
Panel Questionnaire 
History: 
Name: 
E-mail: 
Health: 
1. Do you take any medications which affect your senses, especially taste and smell? 
2. Do you have any allergies to soy foods? 
Daily Living Habits: 
1. How often do you eat out in a week? 
----------------~ 
2. What are your favorite foods? ___________________ _ 
3. What foods do you not like to eat? _________________ _ 
4. What foods can you not eat? __________________ _ 
Flavor Quiz: 
1. How would you describe the difference between flavor and aroma? ______ _ 
2. How would you describe the difference between flavor and texture? ______ _ 
3. Describe some of the noticeable flavors in cola ---------------
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APPENDIXC 
Name: -------
Date: --------
Please taste the samples and indicate whether they are sweet, sour, salty, bitter, or astringent 
by marking an X on the corresponding line. Please rinse with water between samples. You 
do not need to swallow the samples. 
Sample Sweet Sour Salty Bitter Astringent 
Comments: 
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APPENDIXD 
Name: -------
Date: --------
Please rank each coded solution in ascending order of intensity/strength of the solution. 
Code 
Least salty 
Most salty 
Code 
Least sweet 
Most sweet 
Code 
Least bitter 
Most bitter 
Code 
Least sour 
Most sour 
Code 
Least astringent 
Most astringent 
Comments: 
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APPENDIXE 
Instructions: Please taste each sample and evaluate sample for intensity of sour, astringent, 
and bitter flavors, by marking a line on the intensity scale. Hold the sample in your mouth 
for at least 10 seconds and swallow samples if possible. You may use the special rinse 
between samples if it helps you. Remember to swirl the rinse before using. Please open your 
window if you have any problems. Please push your score sheet under the window when 
finished. Thank you 
Sour 
none intense 
Bitter 
none intense 
Astringent 
none intense 
Off Flavor 
none intense 
Comments 
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APPENDIXF 
NAME ---
DATE 
DIRECTIONS: Taste each pair of samples in order, as appears on this scorecard. Indicate 
which sample is more bitter by circling the sample number which corresponds to the more 
bitter sample. Hold the sample in your mouth for at least ten seconds and swallow if 
possible. You may use the special rinse between samples if it helps you. Remember to swirl 
the rinse before using. You may take a break and leave the panel room if you wish. 
Please open your window if you have any problems. Please push your scorecard under your 
window when finished. Thank you. 
Milk samples 
1. 
2. 
3. 
4. 
5. 
6. 
Comments: 
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